Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
17000,,,59559,[],CHEMBL700138,Antibacterial activity tested against Klebsiella pneumoniae (Klebsiella pneumoniae) ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.015
17001,,,59560,[],CHEMBL804821,Antibacterial activity tested against Shigella enteritidis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614594,Shigella,Shigella,620.0,,,MIC,ug ml-1,UO_0000274,,0.015
17002,,,59561,[],CHEMBL770158,Antibacterial activity tested against P. ae (Pseudomonas aeruginosa) ATCC 9027,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
17003,,,59562,[],CHEMBL808152,Antibacterial activity against Staphylococcus aureus MPR 5,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
17004,,,59563,[],CHEMBL808151,Antibacterial activity against Staphylococcus aureus ATCC 6538,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
17005,,,59564,[],CHEMBL814707,Antibacterial activity tested against Staphylococcus epidermidis HCF Berset C,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
17006,,,59565,[],CHEMBL814706,Antibacterial activity tested against Staphylococcus epidermidis CPHL A2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
17007,,,59566,[],CHEMBL813264,Antibacterial activity tested against Streptococcus faecalis LEP Br,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17008,,,59567,[],CHEMBL678823,Inhibitory activity against gyrase supercoiling activity from Escherichia coli,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,IC50,ug.mL-1,,0.68,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,ug ml-1,UO_0000274,,0.68
17009,,,59568,[],CHEMBL623860,CLogP was calculated,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,267402,=,1,1,=,,CLogP,,,-0.805,CHEMBL2362975,,No relevant target,,,,cLogP,,,,-0.805
17010,,,59569,[],CHEMBL810747,Antibacterial activity tested against Staphylococcus aureus; Range is 0.13-2 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
17011,,,59570,[],CHEMBL808157,Antibacterial activity tested against Staphylococcus aureus Methicillin-and Ciprofloxacin resistants; Range is 4-128 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
17012,,,59571,[],CHEMBL858076,Antibacterial activity tested against Streptococcus pneumoniae; Range is 0.5-2 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
17013,,,59572,[],CHEMBL675459,Antibacterial activity tested against Enterococcus faecalis; Range is 0.5-1 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17014,,,59573,[],CHEMBL673984,Antibacterial activity tested against Enterococcus faecium; Range is 1-4 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,1.0
17015,,,59574,[],CHEMBL717546,Efficacy against Septicemia caused by Staphylococcus aureus in mice by Oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,267402,=,1,1,=,,ED50,mg.kg-1,,7.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,7.0
17016,,,59575,[],CHEMBL717547,Efficacy against Septicemia caused by Staphylococcus aureus in mice by subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,267402,=,1,1,=,,ED50,mg.kg-1,,0.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,0.9
17017,,,59576,[],CHEMBL682681,Geometric mean of antibacterial activity (Gram -ve bacteria) of the compound,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,267402,=,1,0,=,,Geometric mean,,,0.033,CHEMBL612545,,Unchecked,,,,Geometric mean,,,,0.033
17018,,,59577,[],CHEMBL682430,Geometric mean of antibacterial activity (Gram +ve bacteria) of the compound,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,267402,=,1,0,=,,Geometric mean,,,0.092,CHEMBL612490,Bacteria,Bacteria,2.0,,,Geometric mean,,,,0.092
17019,,,63715,[],CHEMBL679318,Minimum inhibitory concentration against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132978,J Med Chem,2000.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16225,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
17020,,,67437,[],CHEMBL702885,Binding constant against human serum albumin (HSA),B,,,BAO_0000179,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134302,J Med Chem,2001.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,264398,=,1,0,=,,Log K',,,0.14,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,Log K',,,,0.14
17021,,,79101,[],CHEMBL806924,Minimum Inhibitory concentration measured against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17022,,,79102,[],CHEMBL812354,Minimum Inhibitory concentration measured against Streptococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17023,,,79103,[],CHEMBL809201,Minimum Inhibitory concentration measured against Streptococcus pyogenes ATCC 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
17024,,,79104,[],CHEMBL678958,Minimum Inhibitory concentration measured against Escherichia coli ATCC 1-25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
17025,,,79105,[],CHEMBL762961,Minimum Inhibitory concentration measured against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
17026,,,79106,[],CHEMBL651947,Minimum Inhibitory concentration measured against Bacteroides fragilis ATCC 25285,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,2.0
17027,,,79835,[],CHEMBL681226,Concentration required to produce linear DNA from closed circular DNA by the denaturation of the drug-gyrase-DNA complex,F,,,BAO_0002752,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,0,=,,Concentration,ug ml-1,,0.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,Concentration,ug ml-1,UO_0000274,,0.5
17028,,,79836,[],CHEMBL686626,50% inhibitory concentration against DNA-gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,IC50,ug.mL-1,,5.3,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,5.3
17029,,,79837,[],CHEMBL679145,Antibacterial activity against Escherichia coli H560,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
17030,,,79838,[],CHEMBL679152,Antibacterial activity against Escherichia coli Vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
17031,,,79839,[],CHEMBL703087,Antibacterial activity against Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
17032,,,79840,[],CHEMBL767450,Antibacterial activity against Providencia rettgeri M1771,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.1
17033,,,79841,[],CHEMBL679033,Antibacterial activity against Enterobacter cloacae MA2646,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
17034,,,79842,[],CHEMBL771958,Antibacterial activity against Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
17035,,,79843,[],CHEMBL807357,Antibacterial activity against Staphylococcus aureus H-228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
17036,,,79844,[],CHEMBL807195,Antibacterial activity against Staphylococcus aureus UC76,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17037,,,79845,[],CHEMBL813259,Antibacterial activity against Streptococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
17038,,,79846,[],CHEMBL807987,Antibacterial activity against Streptococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
17039,,,79847,[],CHEMBL808693,Antibacterial activity against Streptococcus pyogenes C203,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
17040,,,79848,[],CHEMBL719159,"Median protective dose against Escherichia coli, determined in acute, lethal systemic infection in female charles river CD-1 mice (po)",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,287526,=,1,0,=,,PD50,mg kg-1,,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.2
17041,,,79849,[],CHEMBL719160,"Median protective dose against Escherichia coli, determined in acute, lethal systemic infection in female charles river CD-1 mice (sc)",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124255,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,287526,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.3
17042,,,82655,[],CHEMBL638024,Cellular permeability (Pc) (Caco-2 cell monolayer),A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134498,J Med Chem,2001.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,99718,=,1,0,=,,Pc,cm s-1,,1900000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Pc,cm s-1,,,1900000.0
17043,,,82656,[],CHEMBL635760,Apparent permeability coefficient (Papp) (Caco-2 cell monolayer),A,,,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134498,J Med Chem,2001.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,99718,=,1,0,=,,Papp,cm s-1,,1700000.0,CHEMBL612558,,ADMET,,,,Papp,cm s-1,,,1700000.0
17044,,,82657,[],CHEMBL851239,Ratio of [(apical to basal)/(basal to apical)] (Caco-2 cell monolayer),A,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134498,J Med Chem,2001.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,99718,=,1,0,=,,Ratio,,,0.44,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,0.44
17045,,,82658,[],CHEMBL637072,Fraction absorbed after oral administration in humans,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134498,J Med Chem,2001.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,99718,=,1,0,=,,FA,,,69.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,FA,,,,69.0
17046,,,85890,[],CHEMBL662294,Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity),F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1125556,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278188,=,1,1,=,,IC50,ug.mL-1,,380.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,,IC50,ug ml-1,UO_0000274,,380.0
17047,,,86832,[],CHEMBL662294,Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity),F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1125556,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278237,=,1,1,=,,IC50,ug.mL-1,,380.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,,IC50,ug ml-1,UO_0000274,,380.0
17048,,,86833,[],CHEMBL682682,Antibacterial activity against five Gram-negative bacteria,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125556,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278237,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.1
17049,,,86834,[],CHEMBL682431,Antibacterial activity against five Gram-positive bacteria targeting topoisomerase II (DNA gyrase B GyrB),F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125556,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278237,=,1,1,=,,MIC,ug.mL-1,,0.91,CHEMBL1921666,Staphylococcus aureus,DNA gyrase subunit B,1280.0,,,MIC,ug ml-1,UO_0000274,,0.91
17050,,,96855,[],CHEMBL662294,Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity),F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1125556,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278208,=,1,1,=,,IC50,ug.mL-1,,380.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,,IC50,ug ml-1,UO_0000274,,380.0
17051,,,96856,[],CHEMBL682682,Antibacterial activity against five Gram-negative bacteria,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125556,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278208,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.1
17052,,,96857,[],CHEMBL682431,Antibacterial activity against five Gram-positive bacteria targeting topoisomerase II (DNA gyrase B GyrB),F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125556,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278208,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL1921666,Staphylococcus aureus,DNA gyrase subunit B,1280.0,,,MIC,ug ml-1,UO_0000274,,0.9
17053,,,106445,[],CHEMBL808753,In vitro minimum inhibitory concentration against Staphylococcus aureus CDC1.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120737,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17054,,,106446,[],CHEMBL808755,In vitro minimum inhibitory concentration against Staphylococcus aureus SN 7.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120737,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
17055,,,106447,[],CHEMBL808754,In vitro minimum inhibitory concentration against Staphylococcus aureus SN 43.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120737,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
17056,,,106448,[],CHEMBL858628,In vitro minimum inhibitory concentration against Staphylococcus aureus COL.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120737,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
17057,,,110126,[],CHEMBL807015,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus (SA1009 CipR),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,,MIC,ug.mL-1,,32000000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,g ml-1,UO_0000274,,32.0
17058,,,110127,[],CHEMBL807352,Antibacterial activity against Staphylococcus aureus (SA1011),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,,MIC,ug.mL-1,,500000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,g ml-1,UO_0000274,,0.5
17059,,,110128,[],CHEMBL808585,Antibacterial activity against linezolid-resistant Staphylococcus aureus (SA1012 LinR),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,,MIC,ug.mL-1,,1000000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,g ml-1,UO_0000274,,1.0
17060,,,110129,[],CHEMBL674674,Antibacterial activity against ciprofloxacin resistant Enterococcus faecium (EF4010 CipR),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,>,1,1,>,,MIC,ug.mL-1,,64000000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,g ml-1,UO_0000274,,64.0
17061,,,110130,[],CHEMBL674676,Antibacterial activity against ciprofloxacin resistant and linezolid-resistant Enterococcus faecium (EF4008 LinR;CipR),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,>,1,1,>,,MIC,ug.mL-1,,64000000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,g ml-1,UO_0000274,,64.0
17062,,,110131,[],CHEMBL674675,Antibacterial activity against ciprofloxacin resistant Enterococcus faecium (EF4016 CipR),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,>,1,1,>,,MIC,ug.mL-1,,64000000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,g ml-1,UO_0000274,,64.0
17063,,,110132,[],CHEMBL676494,Antibacterial activity against ciprofloxacin resistant and linezolid-resistant Enterococcus faecium (EF4011 LinR;CipR),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,>,1,1,>,,MIC,ug.mL-1,,64000000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,g ml-1,UO_0000274,,64.0
17064,,,110133,[],CHEMBL692974,Antibacterial activity against Haemophilus influenzae (HI1008),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,<=,1,1,<=,,MIC,ug.mL-1,,60000.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,g ml-1,UO_0000274,,0.06
17065,,,110134,[],CHEMBL731584,Antibacterial activity against Moraxella catarrhalis (MC1002),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,,MIC,ug.mL-1,,30000.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,g ml-1,UO_0000274,,0.03
17066,,,110135,[],CHEMBL678489,Antibacterial activity against Escherichia coli (EC1008 ),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136460,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,,MIC,ug.mL-1,,30000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,g ml-1,UO_0000274,,0.03
17067,,,129581,[],CHEMBL650967,In vitro minimum inhibitory concentration for Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.06
17068,,,129582,[],CHEMBL649456,In vitro minimum inhibitory concentration for Bacillus cereus ATCC 11778,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.25
17069,,,129583,[],CHEMBL804606,In vitro minimum inhibitory concentration to inhibit Streptococcus faecalis ATCC 10541,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17070,,,129584,[],CHEMBL810362,In vitro minimum inhibitory concentration for Staphylococcus aureus ATCC 25178,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17071,,,129585,[],CHEMBL805306,In vitro minimum inhibitory concentration for Staphylococcus epidermidis ATCC 155-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
17072,,,129586,[],CHEMBL857320,In vitro minimum inhibitory concentration for Pseudomonas aeruginosa ATCC 10145,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
17073,,,129587,[],CHEMBL731863,In vitro minimum inhibitory concentration for Morganella morganii ATCC 8019,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.06
17074,,,129588,[],CHEMBL771727,In vitro minimum inhibitory concentration for Proteus vulgaris ATCC 8427,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.06
17075,,,129589,[],CHEMBL704688,In vitro minimum inhibitory concentration to inhibit Klebsiella pneumoniae ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
17076,,,129590,[],CHEMBL678999,In vitro minimum inhibitory concentration for Escherichia coli ATCC 10799,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
17077,,,129591,[],CHEMBL679446,In vitro minimum inhibitory concentration for Enterobacter cloacae ATCC 23355,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
17078,,,129592,[],CHEMBL720844,"Evaluation of efficacy on systemic infections Staphylococcus aureus HS-93, after oral administration in mice",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257203,=,1,1,=,,ED50,mg.kg-1,,45.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,45.1
17079,,,129593,[],CHEMBL720267,"Evaluation of efficacy on systemic infections Escherichia coli HM-42, after oral administration in mice",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257203,=,1,1,=,,ED50,mg.kg-1,,3.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,3.0
17080,,,129594,[],CHEMBL720843,"Evaluation of efficacy on systemic infections Pseudomonas aeruginosa HS-116, after oral administration in mice",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257203,=,1,1,=,,ED50,mg.kg-1,,70.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,70.3
17081,,,129595,"[{'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '4.0'}]",CHEMBL619436,AUC (0-4 hr) ug/ml/h,A,,,BAO_0002120,BAO_0000366,cell-free format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257203,=,1,1,=,,AUC,ng.hr.mL-1,,2300.0,CHEMBL612558,,ADMET,,,,AUC,ug ml-1 hr-1,,,2.3
17082,,,129596,[],CHEMBL639400,Solubility (buffer pH 7.4),P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127424,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,,Solubility,ug.mL-1,,90.0,CHEMBL2362975,,No relevant target,,,,S,ug ml-1,UO_0000274,,90.0
17083,,,136334,[],CHEMBL671308,In vitro antibacterial activity against Escherichia coli 257,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.0078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0078
17084,,,136335,[],CHEMBL672325,In vitro antibacterial activity against Escherichia coli TEM-1 (constitutive beta-lactamase producer),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.0156,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0156
17085,,,136336,[],CHEMBL658712,In vitro antibacterial activity against Citrobacter freundii BS-16 (constitutive beta-lactamase producer),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.0313,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.0313
17086,,,136337,[],CHEMBL705486,In vitro antibacterial activity against Klebsiella pneumoniae A,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
17087,,,136338,[],CHEMBL675284,In vitro antibacterial activity against Enterobacter cloacae P99 (constitutive beta-lactamase producer),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.0078,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.0078
17088,,,136339,[],CHEMBL805416,In vitro antibacterial activity against Serratia marcescens SM (constitutive beta-lactamase producer),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.0313,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.0313
17089,,,136340,[],CHEMBL767600,In vitro antibacterial activity against Proteus vulgaris ATCC 6380 (constitutive beta-lactamase producer),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.0078,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.0078
17090,,,136341,[],CHEMBL754557,In vitro antibacterial activity against Proteus mirabilis 90,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.0625
17091,,,136342,[],CHEMBL764228,In vitro antibacterial activity against Pseudomonas aeruginosa 8780,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17092,,,136343,[],CHEMBL755266,In vitro antibacterial activity against Pseudomonas aeruginosa 18SH (constitutive beta-lactamase producer),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17093,,,136344,[],CHEMBL812145,In vitro antibacterial activity against Staphylococcus aureus smith,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
17094,,,136345,[],CHEMBL801153,In vitro antibacterial activity against Staphylococcus aureus 67(methicillin resistant),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17095,,,136346,[],CHEMBL801155,In vitro antibacterial activity against Staphylococcus aureus 753 (constitutive beta-lactamase producer),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17096,,,136347,[],CHEMBL813032,In vitro antibacterial activity against Streptococcus pneumoniae 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
17097,,,136348,[],CHEMBL804742,In vitro antibacterial activity against Streptococcus pyogenes 4,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
17098,,,136349,[],CHEMBL654069,In vitro antibacterial activity against Bacteroides fragilis S2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,4.0
17099,,,136350,[],CHEMBL647682,In vitro antibacterial activity against Bacteroides fragilis F117A,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
17100,,,136351,[],CHEMBL876578,In vitro antibacterial activity against Bacteroides thetaiotaomicron 62B,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,128.0
17101,,,136352,[],CHEMBL656336,In vitro antibacterial activity against Clostridium histolyticum 503-86,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL614966,Hathewaya histolytica,Hathewaya histolytica,1498.0,,,MIC,ug ml-1,UO_0000274,,0.125
17102,,,136353,[],CHEMBL652968,In vitro antibacterial activity against Clostridium perfringens 13424,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,0.25
17103,,,136354,[],CHEMBL652963,In vitro antibacterial activity against Clostridium difficile 651,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
17104,,,136355,[],CHEMBL876079,In vitro antibacterial activity against Clostridium difficile 701,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,8.0
17105,,,136356,[],CHEMBL884459,Effect on replication DNA biosynthesis in Escherichia coli H560 (permeabilised cells),F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,IC50,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,ug ml-1,UO_0000274,,0.3
17106,,,136357,[],CHEMBL878140,In vitro antibacterial activity against Escherichia coli UB1005 (nalidixic acid-resistant strain),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
17107,,,136358,[],CHEMBL670215,In vitro antibacterial activity against Escherichia coli 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126202,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
17108,,,139527,[],CHEMBL806091,Minimum inhibitory concentration against Streptococcus aureus (209P),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17109,,,139528,[],CHEMBL811536,Minimum inhibitory concentration in vitro against Streptococcus epidermis (56556),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.2
17110,,,139529,[],CHEMBL809197,Minimum inhibitory concentration in vitro against Streptococcus pyogenes (G36),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,1.56
17111,,,139530,[],CHEMBL858061,Minimum inhibitory concentration in vitro against Streptococcus faecalis (ATCC 19433),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.56
17112,,,139531,[],CHEMBL679319,Minimum inhibitory concentration in vitro against Escherichia coli (NIHJ),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
17113,,,139532,[],CHEMBL700982,Minimum inhibitory concentration in vitro against Klebsiella pneumoniae (type-2),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
17114,,,139533,[],CHEMBL772558,Minimum inhibitory concentration in vitro against Proteus vulgaris (08601),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.013
17115,,,139534,[],CHEMBL677360,Minimum inhibitory concentration in vitro against Escherichia cloacae (03400),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.025
17116,,,139535,[],CHEMBL812935,Minimum inhibitory concentration in vitro against Streptococcus marcescens (10100),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.05
17117,,,139536,[],CHEMBL762951,Minimum inhibitory concentration in vitro against Pseudomonas aeruginosa (32104),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127356,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
17118,,,157971,[],CHEMBL817386,Minimum inhibitory concentration required for primary screening against in-house strain of Streptococcus pneumoniae tested in vitro; Range- 0.2-128,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137072,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307179,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
17119,,,157972,[],CHEMBL689740,Minimum inhibitory concentration required for primary screening against in-house strain of Haemophilus influenzae tested in vitro; Range- 0.004-1,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137072,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307179,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.015
17120,,,157973,[],CHEMBL730797,Minimum inhibitory concentration required for primary screening against in-house strain of Moraxella catarrhalis tested in vitro; Range- 0.03-0.06,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137072,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307179,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.06
17121,,,158734,[],CHEMBL674214,Inhibitory activity against ATCC 13048 strain(Enterobacter aerogenes) in the presence of Norfloxacin and fluoroquinolone at 16 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134275,J Med Chem,2001.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248780,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.025
17122,,,158735,[],CHEMBL674216,Inhibitory activity against ATCC 13048 strain(Enterobacter aerogenes) in the presence of ciprofloxacin fluoroquinolone at 16 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134275,J Med Chem,2001.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248780,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.5
17123,,,158736,[],CHEMBL674221,Inhibitory activity against p9- (derivative of ATCC )13048 strain(Enterobacter aerogenes) in the presence of Norfloxacin and fluoroquinolone at 16 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134275,J Med Chem,2001.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248780,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,32.0
17124,,,164675,[],CHEMBL674579,Tested in vitro for inhibitory activity against gram negative bacteria Escherichia coli ATCC 8739 cell lines at 1 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
17125,,,164676,[],CHEMBL674753,Tested in vitro for inhibitory activity against gram negative bacteria Escherichia coli ISF 432 cell lines at 1 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
17126,,,164677,[],CHEMBL674487,Tested in vitro for inhibitory activity against gram negative bacteria Enterobacter cloacae OMNFI 174 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.01
17127,,,164678,[],CHEMBL636117,Tested in vitro for inhibitory activity against gram negative bacteria Acinetobacter calcoaceticus OSMPV 113 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.06
17128,,,164679,[],CHEMBL858588,Tested in vitro for inhibitory activity against gram negative bacteria Providencia stuartii CNUR 5 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,MIC,ug ml-1,UO_0000274,,0.06
17129,,,164680,[],CHEMBL858367,Tested in vitro for inhibitory activity against gram negative bacteria Klebsiella pneumoniae ATCC 10031 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
17130,,,164681,[],CHEMBL804822,Tested in vitro for inhibitory activity against gram negative bacteria Shigella enteritidis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614594,Shigella,Shigella,620.0,,,MIC,ug ml-1,UO_0000274,,0.03
17131,,,164682,[],CHEMBL858596,Tested in vitro for inhibitory activity against gram negative bacteria Pseudomonas aeruginosa ATCC 9027 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
17132,,,164683,[],CHEMBL810562,Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus aureus MPR 5 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
17133,,,164684,[],CHEMBL810561,Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus aureus ATCC 6538 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
17134,,,164685,[],CHEMBL805358,Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus epidermidis HCF berset C strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
17135,,,164686,[],CHEMBL856962,Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus epidermidis CPHL A2 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
17136,,,164687,[],CHEMBL812358,Tested in vitro for inhibitory activity against gram positive bacteria Streptococcus faecalis LEP Br strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17137,,,164688,[],CHEMBL844930,Minimum concentration at which cleaved linear DNA is observed,F,,,BAO_0002752,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128274,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,0,=,,Concentration,ug ml-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Concentration,ug ml-1,UO_0000274,,1.0
17138,,,169996,[],CHEMBL798727,In vitro antibacterial activity against Staphylococcus aureus Smith (A9537),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
17139,,,169997,[],CHEMBL671304,In vitro antibacterial activity against Escherichia coli (A 15119),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
17140,,,169998,[],CHEMBL702897,In vitro antibacterial activity against Klebsiella pneumoniae (A 9664),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
17141,,,169999,[],CHEMBL674190,In vitro antibacterial activity against Enterobacter cloacae (A 9656),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
17142,,,170000,[],CHEMBL706441,In vitro antibacterial activity against Morganella morganii (A 15153),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.015
17143,,,170001,[],CHEMBL754842,In vitro antibacterial activity against Pseudomonas aeruginosa (A 9843),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.13
17144,,,170002,[],CHEMBL798728,In vivo efficacy in systemic infection due to Staphylococcus aureus Smith (A 9537) in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,295235,=,1,0,=,,PD50,mg kg-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,4.0
17145,,,170003,[],CHEMBL754843,In vivo efficacy in systemic infection due to Pseudomonas aeruginosa (A 9843) in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,295235,=,1,0,=,,PD50,mg kg-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,5.0
17146,,,170004,[],CHEMBL671305,In vivo efficacy in systemic infection due to Escherichia coli (A 15119) in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,295235,=,1,0,=,,PD50,mg kg-1,,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.7
17147,,,170005,[],CHEMBL702898,In vivo efficacy in systemic infection due to Klebsiella pneumoniae (A 9664) in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,295235,=,1,0,=,,PD50,mg kg-1,,1.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,PD50,mg kg-1,UO_0000308,,1.5
17148,,,170006,[],CHEMBL727606,Lethal dose of compound in OF1-strain female swiss mice after oral administration,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,295235,>,1,1,>,,LD50,mg.kg-1,,2500.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,2500.0
17149,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,170007,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL626035,Maximum concentration in plasma after oral administration in dog (25 mg/kg),A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,295235,=,1,1,=,,Cmax,nM,,9053.87,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,Cmax,ug ml-1,UO_0000065,,3.0
17150,,,170008,[],CHEMBL636483,Half-life in plasma after oral administration in dog (25 mg/kg),A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,295235,=,1,1,=,,T1/2,hr,,3.5,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,T1/2,hr,UO_0000032,,3.5
17151,,,170009,[],CHEMBL622607,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,0,=,,AUC,ug ml-1,,20.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,AUC,ug ml-1,UO_0000274,,20.0
17152,,,170010,[],CHEMBL637199,Urinary recovery after 24 hr in plasma after oral administration in dog (25 mg/kg),A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,295235,=,1,0,=,,UR,%,,17.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,UR,%,UO_0000187,,17.0
17153,,,179021,[],CHEMBL711511,Concentration required to reduce the viability of mock-infected MT-4 cells by 50%,F,,,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,CC50,nM,,60000.0,CHEMBL388,Homo sapiens,MT4,9606.0,,,CC50,uM,UO_0000065,,60.0
17154,,,179022,[],CHEMBL748685,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium fortuitum (clinical isolate) by 50%,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC50,nM,,1500.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC50,uM,UO_0000065,,1.5
17155,,,179023,[],CHEMBL748687,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium fortuitum (clinical isolate) by 90%,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC90,nM,,4000.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC90,uM,UO_0000065,,4.0
17156,,,179024,[],CHEMBL748704,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium smegmatis ATCC 19420 by 50%,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC50,nM,,8800.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC50,uM,UO_0000065,,8.8
17157,,,179025,[],CHEMBL749707,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium smegmatis ATCC 19420 by 90%,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC90,nM,,1000.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC90,uM,UO_0000065,,1.0
17158,,,179026,[],CHEMBL748579,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium avium complex (MAC) ATCC 49601 by 50%,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC50,nM,,2000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC50,uM,UO_0000065,,2.0
17159,,,179027,[],CHEMBL748582,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium avium complex (MAC) ATCC 49601 by 90%,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC90,nM,,3000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC90,uM,UO_0000065,,3.0
17160,,,179028,[],CHEMBL749512,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium tuberculosis ATCC 27294 by 50%,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC50,nM,,1500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,1.5
17161,,,179029,[],CHEMBL749683,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium tuberculosis ATCC 27294 by 90%,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC90,nM,,3000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,3.0
17162,,,179030,[],CHEMBL749513,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium tuberculosis clinical isolate 1104 by 50%,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC50,nM,,1000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,1.0
17163,,,179031,[],CHEMBL749684,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium tuberculosis clinical isolate 1104 by 90%,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC90,nM,,1500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,1.5
17164,,,179032,[],CHEMBL809344,Minimum inhibitory concentration required in vitro against Streptococcus D,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC,nM,,400.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,uM,UO_0000065,,0.4
17165,,,179033,[],CHEMBL809342,Minimum bactericidal concentration required in vitro against Streptococcus D,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,72040,=,1,0,=,,MBC,uM,,0.8,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MBC,uM,UO_0000064,,0.8
17166,,,179034,[],CHEMBL809943,Minimum inhibitory concentration required in vitro against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC,nM,,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.4
17167,,,179035,[],CHEMBL883384,Minimum bactericidal concentration required in vitro against Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,72040,=,1,0,=,,MBC,uM,,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM,UO_0000064,,0.4
17168,,,179036,[],CHEMBL803170,Minimum inhibitory concentration required in vitro against Salmonella,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC,nM,,10.0,CHEMBL614446,Salmonella,Salmonella,590.0,,,MIC,uM,UO_0000065,,0.01
17169,,,179037,[],CHEMBL801277,Minimum bactericidal concentration required in vitro against Salmonella,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,72040,=,1,0,=,,MBC,uM,,0.01,CHEMBL614446,Salmonella,Salmonella,590.0,,,MBC,uM,UO_0000064,,0.01
17170,,,179038,[],CHEMBL804812,Minimum inhibitory concentration required in vitro against Shigella,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,,MIC,nM,,10.0,CHEMBL614594,Shigella,Shigella,620.0,,,MIC,uM,UO_0000065,,0.01
17171,,,179039,[],CHEMBL804810,Minimum bactericidal concentration required in vitro against Shigella,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,72040,=,1,0,=,,MBC,uM,,0.01,CHEMBL614594,Shigella,Shigella,620.0,,,MBC,uM,UO_0000064,,0.01
17172,,,206171,[],CHEMBL858470,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17173,,,206172,[],CHEMBL878428,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
17174,,,206173,[],CHEMBL752157,Antibacterial activity against human Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
17175,,,206174,[],CHEMBL752156,Antibacterial activity against Mycobacterium tuberculosis H331,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.125
17176,,,206175,[],CHEMBL752155,Antibacterial activity against Mycobacterium tuberculosis H242,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.125
17177,,,206176,[],CHEMBL752154,Antibacterial activity against Mycobacterium tuberculosis H172,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
17178,,,208648,[],CHEMBL682683,Geometric mean of MIC was determined in vitro against gram-negative strains using standard microtitration techniques,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126729,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,102932,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.05
17179,,,208649,[],CHEMBL682432,Geometric mean of MIC was determined in vitro against gram-positive strains using standard microtitration techniques,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126729,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,102932,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL612490,Bacteria,Bacteria,2.0,,,MIC,ug ml-1,UO_0000274,,0.6
17180,,,208650,[],CHEMBL722019,"Protective dose in vivo was determined in acute, lethal systemic infections in female Charles River CD-1 mice against Escherichia coli Vogel",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126729,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,102932,=,1,0,=,,PD50,mg kg-1,,1.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.2
17181,,,208651,[],CHEMBL723680,"Protective dose in vivo was determined in acute, lethal systemic infections in female Charles River CD-1 mice against Streptococcus pyogenes C-203",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126729,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,102932,>,1,0,>,,PD50,mg kg-1,,260.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,260.0
17182,,,208652,[],CHEMBL658171,Inhibition of the gyrase mediated cleavage of supercoiled DNA,F,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126729,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,102932,=,1,1,=,,IC50,ug.mL-1,,5.3,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,5.3
17183,,,211463,[],CHEMBL672107,"Antibacterial activity against gram negative organism, Escherichia cloacae (MA2646)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.013
17184,,,211464,[],CHEMBL674333,"Antibacterial activity was determined against gram negative organism, E. coli(vogel)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.013
17185,,,211465,[],CHEMBL706025,"Antibacterial activity was determined against gram negative organism, K. pneumoniae (MGH-2)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
17186,,,211466,[],CHEMBL755846,"Antibacterial activity was determined against gram negative organism, Providencia rettgeri. (M1771)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612490,Bacteria,Bacteria,2.0,,,MIC,ug ml-1,UO_0000274,,0.05
17187,,,211467,[],CHEMBL755262,"Antibacterial activity was determined against gram negative organism, Pseudomonas aeruginosa (UI-18)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
17188,,,211468,[],CHEMBL805136,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus (H228)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.6
17189,,,211469,[],CHEMBL805137,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus (UC76)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17190,,,211470,[],CHEMBL799852,"Antibacterial activity was determined against gram positive organism, Streptococcus faecalis (MGH-2)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
17191,,,211471,[],CHEMBL799744,"Antibacterial activity was determined against gram positive organism, Streptococcus pneumoniae (SV-1)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.8
17192,,,211472,[],CHEMBL801924,"Antibacterial activity was determined against gram positive organism, Streptococcus pyogenes (C203)",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
17193,,,211473,[],CHEMBL875406,Minimum inhibitory concentration required to inhibit DNA gyrase supercoiling.,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,0,=,,DNA cleavage,ug ml-1,,0.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,DNA cleavage,ug ml-1,UO_0000274,,0.5
17194,,,211474,[],CHEMBL721982,In vivo oral protective dose was determined in female charles river CD-1 mice infected with Escherichia coli (vogel),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,18071,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.0
17195,,,211475,[],CHEMBL721992,In vivo subcutaneous protective dose was determined in female charles river CD-1 mice infected with Escherichia coli (vogel),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,18071,=,1,0,=,,PD50,mg kg-1,,0.25,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.25
17196,,,211476,[],CHEMBL721983,In vivo oral protective dose was determined in female charles river CD-1 mice infected with Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,18071,=,1,0,=,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
17197,,,211477,[],CHEMBL719151,In vivo subcutaneous protective dose was determined in female charles river CD-1 mice infected with Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,18071,=,1,0,=,,PD50,mg kg-1,,19.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,19.0
17198,,,211478,[],CHEMBL847744,MIC ratio measured as the mean MICs of gram-negative bacteria,F,,,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,18071,=,1,0,=,,Ratio,,,0.044,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.044
17199,,,211479,[],CHEMBL847746,MIC ratio measured as the mean MICs of gram-positive bacteria,F,,,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,18071,=,1,0,=,,Ratio,,,0.7,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.7
17200,,,218482,[],CHEMBL808675,In vitro antibacterial activity against Staphylococcus aureus 209P JC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17201,,,218483,[],CHEMBL879522,In vitro antibacterial activity against Micrococcus luteus ATCC 9341,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,1.56
17202,,,218484,[],CHEMBL676903,In vitro antibacterial activity against Escherichia coli NIH JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,,MIC,ug.mL-1,,0.0125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0125
17203,,,218485,[],CHEMBL703017,In vitro antibacterial activity against Klebsiella pneumoniae K-1966,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.006
17204,,,218486,[],CHEMBL805413,In vitro antibacterial activity against Serratia marcescens IFO 3736,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.1
17205,,,218487,[],CHEMBL803874,In vitro antibacterial activity against Shigella flexneri 2a EW-10,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC,ug ml-1,UO_0000274,,0.006
17206,,,218488,[],CHEMBL764321,In vitro antibacterial activity against Pseudomonas aeruginosa E-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17207,,,218489,[],CHEMBL722519,Compound was evaluated for oral efficacy on systemic infections in mice by Escherichia coli KC-14,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,277780,=,1,1,=,,ED50,mg.kg-1,,0.45,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,0.45
17208,,,218490,[],CHEMBL722520,Compound was evaluated for oral Pseudomonas aeruginosa E-2,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125554,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,277780,=,1,1,=,,ED50,mg.kg-1,,9.01,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,9.01
17209,,,237547,[],CHEMBL681593,Antibacterial activity was evaluated against Escherichia coli,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148326,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,204678,=,1,0,=,,Log 1/C,,,7.66,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Log 1/C,,,,7.66
17210,,,237548,[],CHEMBL771945,Antibacterial activity was evaluated against Pseudomonas aeruginosa,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148326,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,204678,=,1,0,=,,Log 1/C,,,6.77,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Log 1/C,,,,6.77
17211,,,237549,[],CHEMBL810860,Antibacterial activity was evaluated against Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148326,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,204678,=,1,0,=,,Log 1/C,,,6.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Log 1/C,,,,6.16
17212,,,237550,[],CHEMBL673141,Antibacterial activity evaluated against Enterococcus faecalis,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148326,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,204678,=,1,0,=,,Log 1/C,,,6.16,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Log 1/C,,,,6.16
17213,,,247502,[],CHEMBL812454,In vitro antibacterial activity against Staphylococcus aureus ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17214,,,247503,[],CHEMBL810887,In vitro antibacterial activity against Staphylococcus aureus CMX 686B,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17215,,,247504,[],CHEMBL804404,In vitro antibacterial activity against Staphylococcus epidermis 3519,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.39
17216,,,247505,[],CHEMBL812911,In vitro antibacterial activity against Streptococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.2
17217,,,247506,[],CHEMBL808966,In vitro antibacterial activity against Streptococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.39
17218,,,247507,[],CHEMBL679386,In vitro antibacterial activity against Escherichia coli Juhl,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
17219,,,247508,[],CHEMBL678424,In vitro antibacterial activity against Enterobacter aerogenes ATCC 13048,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.05
17220,,,247509,[],CHEMBL700095,In vitro antibacterial activity against Klebsiella pneumoniae 8045,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.02
17221,,,247510,[],CHEMBL858595,In vitro antibacterial activity against Pseudomonas aeruginosa 5007,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
17222,,,247511,[],CHEMBL772484,In vitro antibacterial activity against Pseudomonas aeruginosa K799/WT,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
17223,,,247512,[],CHEMBL857908,In vitro antibacterial activity against Acinetobacter CMX 669,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,1.56
17224,,,247513,[],CHEMBL810293,In vitro mouse protection test against Staphylococcus aureus NCTC 10649 (100 X LD50) (s.c. administration );Range is between (1.0-2.5),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,288275,=,1,1,=,,ED50,mg.kg-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,1.6
17225,,,247514,[],CHEMBL810292,In vitro mouse protection test against Staphylococcus aureus NCTC 10649 (100 X LD50) (p.o. administration );Range is between (9.9-24.1),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,288275,=,1,1,=,,ED50,mg.kg-1,,15.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,15.5
17226,,,247515,[],CHEMBL675616,In vitro mouse protection test against Escherichia coli Juhl (100 X LD50) (s.c. administration );Range is between (0.1-0.2),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,288275,=,1,1,=,,ED50,mg.kg-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,0.2
17227,,,247516,[],CHEMBL678378,In vitro mouse protection test against Escherichia coli Juhl (100 X LD50) (p.o. administration );Range is between (1.2-3.0),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,288275,=,1,1,=,,ED50,mg.kg-1,,1.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,1.9
17228,,,247517,[],CHEMBL764789,In vitro mouse protection test against Pseudomonas aeruginosa 5007 (100 X LD50) (subcutaneous administration; Range is between (1.1-3.8).,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,288275,=,1,1,=,,ED50,mg.kg-1,,2.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,2.1
17229,,,247518,[],CHEMBL764791,In vitro mouse protection test against Pseudomonas aeruginosa 5007 (100 X LD50) (p.o. administration ); Range is between (6.8-26.2).,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,288275,=,1,1,=,,ED50,mg.kg-1,,13.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,13.3
17230,,,255377,[],CHEMBL804630,In vitro minimum inhibitory concentration against Staphylococcus aureus ATCC 6538P using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17231,,,255378,[],CHEMBL805070,In vitro minimum inhibitory concentration against Staphylococcus aureus CMX 553 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17232,,,255379,[],CHEMBL805068,In vitro minimum inhibitory concentration against Staphylococcus aureus A 5177 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17233,,,255380,[],CHEMBL806912,In vitro minimum inhibitory concentration against Staphylococcus aureus NCTC 10649 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17234,,,255381,[],CHEMBL806914,In vitro minimum inhibitory concentration against Staphylococcus epidermidis 3159 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.39
17235,,,255382,[],CHEMBL674277,In vitro minimum inhibitory concentration against Enterococcus faecium ATCC 8043 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.39
17236,,,255383,[],CHEMBL811088,In vitro minimum inhibitory concentration against Streptococcus bovis A5169 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,1.56
17237,,,255384,[],CHEMBL813305,In vitro minimum inhibitory concentration against Streptococcus agalactiae CMX 508 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.39
17238,,,255385,[],CHEMBL813963,In vitro minimum inhibitory concentration against Streptococcus pyogenes 930 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.39
17239,,,255386,[],CHEMBL676895,In vitro minimum inhibitory concentration against Escherichia coli Juhl using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
17240,,,255387,[],CHEMBL680772,In vitro minimum inhibitory concentration against Enterobacter aerogenes ATCC 13048 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.05
17241,,,255388,[],CHEMBL703170,In vitro minimum inhibitory concentration against Klebsiella pneumoniae 8045 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.02
17242,,,255389,[],CHEMBL764308,In vitro minimum inhibitory concentration against Pseudomonas aeruginosa A5007 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17243,,,255390,[],CHEMBL761100,In vitro minimum inhibitory concentration against Pseudomonas aeruginosa K799 / WT using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17244,,,255391,[],CHEMBL644945,In vitro minimum inhibitory concentration against Acinetobacter CMX 669 using brain-heart infusion agar,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,0.78
17245,,,255392,[],CHEMBL811371,In vivo antibacterial activity against Staphylococcus aureus NCTC 10649 infected mouse by oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,45088,=,1,1,=,,ED50,mg.kg-1,,15.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,15.5
17246,,,255393,[],CHEMBL811372,In vivo antibacterial activity against Staphylococcus aureus NCTC 10649 infected mouse by subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125434,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,45088,=,1,1,=,,ED50,mg.kg-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,1.6
17247,,,269317,[],CHEMBL673664,In vitro minimum inhibitory concentration was measured against Escherichia coli 257 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17248,,,269318,[],CHEMBL673666,In vitro minimum inhibitory concentration was measured against Escherichia coli ATCC 25922 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17249,,,269319,[],CHEMBL673668,In vitro minimum inhibitory concentration was measured against Escherichia coli TEM-1 (Beta lactamase producer) strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
17250,,,269320,[],CHEMBL663432,In vitro minimum inhibitory concentration was measured against Citrobacter freundii BS-16 (beta lactamase producer) strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.031
17251,,,269321,[],CHEMBL704687,In vitro minimum inhibitory concentration was measured against Klebsiella pneumoniae A strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
17252,,,269322,[],CHEMBL679442,In vitro minimum inhibitory concentration was measured against Enterobacter cloacae 5699 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.016
17253,,,269323,[],CHEMBL679443,In vitro minimum inhibitory concentration was measured against Enterobacter cloacae p99 (beta lactamase producer) strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
17254,,,269324,[],CHEMBL802091,In vitro minimum inhibitory concentration was measured against Serratia marcescens 1071(beta lactamase producer) strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.063
17255,,,269325,[],CHEMBL771726,In vitro minimum inhibitory concentration was measured against Proteus vulgaris 1028BC (beta lactamase producer) strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.016
17256,,,269326,[],CHEMBL763279,In vitro minimum inhibitory concentration was measured against Proteus mirabilis 90 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.063
17257,,,269327,[],CHEMBL769410,In vitro minimum inhibitory concentration was measured against Pseudomonas aeruginosa 8780 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17258,,,269328,[],CHEMBL769409,In vitro minimum inhibitory concentration was measured against Pseudomonas aeruginosa 18S/H strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17259,,,269329,[],CHEMBL810763,In vitro minimum inhibitory concentration was measured against Staphylococcus aureus smith strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
17260,,,269330,[],CHEMBL810761,In vitro minimum inhibitory concentration was measured against Staphylococcus aureus 67-0 (Methicillin resistant) strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17261,,,269331,[],CHEMBL810762,In vitro minimum inhibitory concentration was measured against Staphylococcus aureus 753 (Methicillin resistant) strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17262,,,269332,[],CHEMBL725480,In vitro minimum inhibitory concentration was measured against Micrococcus luteus ATCC 9341 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
17263,,,269333,[],CHEMBL813978,In vitro minimum inhibitory concentration was measured against Streptococcus pneumoniae 6301 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
17264,,,269334,[],CHEMBL818111,In vitro minimum inhibitory concentration was measured against Streptococcus pyogenes 4 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
17265,,,269335,[],CHEMBL677618,In vitro minimum inhibitory concentration was measured against Enterococcus faecalis ATCC 29212 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
17266,,,269336,[],CHEMBL703074,Tested for its efficacy against systemic murine infection caused by Klebsiella pneumoniae A,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,=,1,1,=,,ED50,mg.kg-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,ED50,mg kg-1,UO_0000308,,1.0
17267,,,269337,[],CHEMBL878285,Tested for its efficacy against systemic murine infection caused by Enterobacter cloacae 5699.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,=,1,1,=,,ED50,mg.kg-1,,0.2,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,ED50,mg kg-1,UO_0000308,,0.2
17268,,,269338,[],CHEMBL810615,Tested for its efficacy against systemic murine infection caused by Serratia marcescens SM.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,<,1,1,<,,ED50,mg.kg-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,ED50,mg kg-1,UO_0000308,,0.5
17269,,,269339,[],CHEMBL770182,Tested for its efficacy against systemic murine infection caused by Pseudomonas aeruginosa 8780.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,=,1,1,=,,ED50,mg.kg-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,4.0
17270,,,269340,[],CHEMBL814105,Tested for its efficacy against systemic murine infection caused by Staphylococcus aureus smith.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,=,1,1,=,,ED50,mg.kg-1,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,3.0
17271,,,269341,[],CHEMBL809730,Tested for its efficacy against systemic murine infection caused by Streptococcus pneumoniae 6301.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,100.0
17272,,,269342,[],CHEMBL703080,Bacterial challenge for systemic murine infection against Klebsiella pneumoniae A,A,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,=,1,0,=,,LD50,,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,LD50,,,,1.0
17273,,,269343,[],CHEMBL678370,Bacterial challenge for systemic murine infection against Enterobacter cloacae 5699,A,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,=,1,0,=,,LD50,,,0.2,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,LD50,,,,0.2
17274,,,269344,[],CHEMBL810620,Bacterial challenge for systemic murine infection against Serratia marcescens SM,A,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,<,1,0,<,,LD50,,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,LD50,,,,0.5
17275,,,269345,[],CHEMBL771944,Bacterial challenge for systemic murine infection against Pseudomonas aeruginosa 8780,A,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,=,1,0,=,,LD50,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,LD50,,,,4.0
17276,,,269346,[],CHEMBL810858,Bacterial challenge for systemic murine infection against Staphylococcus aureus Smith,A,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,=,1,0,=,,LD50,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,LD50,,,,3.0
17277,,,269347,[],CHEMBL807982,Bacterial challenge for systemic murine infection against Streptococcus pneumoniae 6301,A,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127320,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,251200,>,1,0,>,,LD50,,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,LD50,,,,100.0
17278,,,295057,[],CHEMBL678474,Anti-bacterial activity was tested against Gram-negative EC-1 bacterium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
17279,,,295058,[],CHEMBL771949,Anti-bacterial activity tested against Gram-negative PA-7 bacterium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17280,,,295059,[],CHEMBL807339,Anti-bacterial activity was tested against Gram-positive SA-13 bacterium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
17281,,,295060,[],CHEMBL807780,Anti-bacterial activity tested against Gram-positive SP1-1 bacterium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.4
17282,,,295061,[],CHEMBL748677,Anti-bacterial activity tested against Mycobacterium fortuitum (ATCG 6841),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,0.06
17283,,,295062,[],CHEMBL752176,Anti-bacterial activity tested against Mycobacterium smegmatis (ATCG 19420),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.25
17284,,,295063,[],CHEMBL631421,Calculated partition coefficient (clogP),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,320278,=,1,1,=,,CLogP,,,2.04,CHEMBL2362975,,No relevant target,,,,clogP,,,,2.04
17285,,,299228,[],CHEMBL671309,The compound was tested in vitro for minimum inhibitory concentration against Escherichia coli 257,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17286,,,299229,[],CHEMBL670505,The compound was tested in vitro for minimum inhibitory concentration against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17287,,,299230,[],CHEMBL674327,The compound was tested in vitro for minimum inhibitory concentration against Escherichia coli TEM-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
17288,,,299231,[],CHEMBL660518,The compound was tested in vitro for minimum inhibitory concentration against Citrobacter Freundii BS-16,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.031
17289,,,299232,[],CHEMBL858368,The compound was tested in vitro for minimum inhibitory concentration against Klebsiella pneumoniae A,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
17290,,,299233,[],CHEMBL675287,The compound was tested in vitro for minimum inhibitory concentration against Enterobacter cloacae P99,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
17291,,,299234,[],CHEMBL805876,The compound was tested in vitro for minimum inhibitory concentration against Serratia marcescens 1071,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.063
17292,,,299235,[],CHEMBL767598,The compound was tested in vitro for minimum inhibitory concentration against Proteus vulgaris 1028 BC,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.016
17293,,,299236,[],CHEMBL754955,The compound was tested in vitro for minimum inhibitory concentration against Proteus mirabilis 90,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.063
17294,,,299237,[],CHEMBL764230,The compound was tested in vitro for minimum inhibitory concentration against Pseudomonas aeruginosa 8780,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17295,,,299238,[],CHEMBL755263,The compound was tested in vitro for minimum inhibitory concentration against Pseudomonas aeruginosa 18S/H,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17296,,,299239,[],CHEMBL813935,The compound was tested in vitro for minimum inhibitory concentration against Staphylococcus aureus smith,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
17297,,,299240,[],CHEMBL800025,The compound was tested in vitro for minimum inhibitory concentration against Staphylococcus aureus 67-0,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17298,,,299241,[],CHEMBL800027,The compound was tested in vitro for minimum inhibitory concentration against Staphylococcus aureus 753,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17299,,,299242,[],CHEMBL731807,The compound was tested in vitro for minimum inhibitory concentration against Micrococcus luteus ATCC 9341,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
17300,,,299243,[],CHEMBL813034,The compound was tested in vitro for minimum inhibitory concentration against Streptococcus pneumoniae 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
17301,,,299244,[],CHEMBL802625,The compound was tested in vitro for minimum inhibitory concentration against Streptococcus pyogenes,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
17302,,,299245,[],CHEMBL673576,The compound was tested in vitro for minimum inhibitory concentration against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
17303,,,299246,[],CHEMBL678824,Inhibitory activity on replicative DNA biosynthesis in Escherichia coli H560 (permeabilised cells),F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,IC50,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,ug ml-1,UO_0000274,,0.3
17304,,,299247,[],CHEMBL672326,Minimum inhibitory concentration required to inhibit the activity of Escherichia coli UB1005,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
17305,,,299248,[],CHEMBL670834,Minimum inhibitory concentration required to inhibit the activity of Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
17306,,,299249,[],CHEMBL802618,Effective dose against mouse infected with Staphylococcus aureus 753 (MR) (LDs-6),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,179871,=,1,1,=,,ED50,mg.kg-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,2.0
17307,,,299250,[],CHEMBL807265,Effective dose against mouse infected with Streptococcus pneumoniae 6301(LDs-5623),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,179871,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,50.0
17308,,,299251,[],CHEMBL761062,Effective dose against mouse infected with Pseudomonas aeruginosa 8780 (LDs-240),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125212,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,179871,=,1,1,=,,ED50,mg.kg-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,3.0
17309,,,306191,[],CHEMBL808062,Tested for minimum inhibitory concentration against Staphylococcus aureus 209P,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17310,,,306192,[],CHEMBL808063,Tested for minimum inhibitory concentration against Staphylococcus aureus Smith,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
17311,,,306193,[],CHEMBL806934,Tested for minimum inhibitory concentration against Staphylococcus epidermidis 56556,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.2
17312,,,306194,[],CHEMBL812972,Tested for minimum inhibitory concentration against Streptococcus pyogenes G-36,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.78
17313,,,306195,[],CHEMBL680783,Tested for minimum inhibitory concentration against Enterococcus faecalis ATCC 19433,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.78
17314,,,306196,[],CHEMBL682917,Tested for minimum inhibitory concentration against Escherichia coli NIHJ,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
17315,,,306197,[],CHEMBL767452,Tested for minimum inhibitory concentration against Proteus vulgaris 08601,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,,MIC,ug.mL-1,,0.05,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.05
17316,,,306198,[],CHEMBL858365,Tested for minimum inhibitory concentration against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
17317,,,306199,[],CHEMBL678006,Tested for minimum inhibitory concentration against Enterobacter cloacae 03400,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
17318,,,306200,[],CHEMBL763138,Tested for minimum inhibitory concentration against Pseudomonas aeruginosa 32121,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,,MIC,ug.mL-1,,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.05
17319,,,306201,[],CHEMBL682916,Tested for minimum inhibitory concentration against Escherichia coli KL-16,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
17320,,,306202,[],CHEMBL658172,Dose required to inhibit DNA gyrase in Escherichia coli,B,,,BAO_0000179,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,0,=,,ID50,ug ml-1,,0.13,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,ID50,ug ml-1,UO_0000274,,0.13
17321,,,306203,[],CHEMBL632370,Partition coefficient of the compound,A,,,BAO_0002131,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127078,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,219131,=,1,0,=,,PKa,,,0.89,CHEMBL612558,,ADMET,,,,PKa,,,,0.89
17322,,,319298,[],CHEMBL682975,In vitro antibacterial activity was tested for Enterobacter cloacae HA2646,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
17323,,,319299,[],CHEMBL682187,In vitro antibacterial activity was tested for Escherichia coli Vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
17324,,,319300,[],CHEMBL682186,In vitro antibacterial activity was tested for Escherichia coli H560,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
17325,,,319301,[],CHEMBL703008,In vitro antibacterial activity was tested for Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
17326,,,319302,[],CHEMBL767624,In vitro antibacterial activity was tested for Providencia rettgeri H1771,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.1
17327,,,319303,[],CHEMBL772736,In vitro antibacterial activity was tested for Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
17328,,,319304,[],CHEMBL809865,In vitro antibacterial activity was tested for Staphylococcus aureus H228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
17329,,,319305,[],CHEMBL809866,In vitro antibacterial activity was tested for Staphylococcus aureus UC-76,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17330,,,319306,[],CHEMBL814002,In vitro antibacterial activity was tested for Streptococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
17331,,,319307,[],CHEMBL812243,In vitro antibacterial activity was tested for Streptococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
17332,,,319308,[],CHEMBL813819,In vitro antibacterial activity was tested for Streptococcus pyogenes C203,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
17333,,,319309,[],CHEMBL648899,In vitro antibacterial activity against Bacteroides fragilis BFA,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,3.1
17334,,,319310,[],CHEMBL656328,In vitro antibacterial activity was tested for Clostridium diff CD1-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,6.3
17335,,,319311,[],CHEMBL659029,In vitro antibacterial activity against Clostridium perfringens CP 3-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.4
17336,,,319312,[],CHEMBL858580,In vitro antibacterial activity was tested for Propion acnes PA5-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.8
17337,,,319313,[],CHEMBL765433,In vitro antibacterial activity was tested for Pepto asac PA 3-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,1.6
17338,,,319314,[],CHEMBL812296,Clonogenic cytotoxicity against Chinese hamster V-79 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,>,1,1,>,,IC50,ug.mL-1,,320.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,,IC50,ug ml-1,UO_0000274,,320.0
17339,,,319315,[],CHEMBL722857,Phototoxic skin reaction in depilated female CD-1 mice,T,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,269115,=,1,0,=,,PTD50,mg,,172.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PTD50,mg,UO_0000022,,172.0
17340,,,319316,[],CHEMBL726281,Phototoxic skin reaction in depilated female CD-1 mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,269115,=,1,0,=,,No effect dose,mg,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,No effect dose,mg,UO_0000022,,100.0
17341,,,322526,[],CHEMBL682417,Minimum inhibitory concentration against Enterobacter cloacae HA 2646 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
17342,,,322527,[],CHEMBL721988,In vivo potency against Streptococcus pneumoniae using mouse protection assay following p.o. administration.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,349166,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,100.0
17343,,,322528,[],CHEMBL721986,In vivo potency against Staphylococcus aureus using mouse protection assay following p.o. administration.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,349166,=,1,0,=,,PD50,mg kg-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,25.0
17344,,,322529,[],CHEMBL721984,In vivo potency against Escherichia coli vogel using mouse protection assay when given perorally,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,349166,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.0
17345,,,322530,[],CHEMBL675260,Minimum inhibitory concentration against Escherichia coli vogel in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
17346,,,322531,[],CHEMBL675259,Minimum inhibitory concentration against Escherichia coli H560 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
17347,,,322532,[],CHEMBL700811,Minimum inhibitory concentration against Klebsiella pneumoniae MGH-2 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
17348,,,322533,[],CHEMBL772085,Minimum inhibitory concentration against Providencia rettgeri H1771 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.1
17349,,,322534,[],CHEMBL764205,Minimum inhibitory concentration against Pseudomonas aeruginosa UI-18 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
17350,,,322535,[],CHEMBL810157,Minimum inhibitory concentration against Staphylococcus aureus H228 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
17351,,,322536,[],CHEMBL810158,Minimum inhibitory concentration against Staphylococcus aureus UC-76 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17352,,,322537,[],CHEMBL814016,Minimum inhibitory concentration against Streptococcus faecalis MGH-2 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
17353,,,322538,[],CHEMBL810071,Minimum inhibitory concentration against Streptococcus pneumoniae SV-1 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
17354,,,322539,[],CHEMBL809185,Minimum inhibitory concentration against Streptococcus pyogenes C203 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
17355,,,322540,[],CHEMBL675210,Minimum concentration needed to produce linear DNA at an intensity relative to oxolinic at 10 ug/mL in Escherichia coli H560 in vitro.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,349166,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
17356,,,322541,[],CHEMBL721985,In vivo potency against Escherichia coli vogel using mouse protection assay when given subcutaneously,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,349166,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.3
17357,,,322542,[],CHEMBL721987,In vivo potency against Staphylococcus aureus using mouse protection assay following s.c. administration.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,349166,=,1,0,=,,PD50,mg kg-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,5.0
17358,,,322543,[],CHEMBL857249,In vivo potency against Streptococcus pneumoniae using mouse protection assay following s.c. administration.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124270,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,349166,>,1,0,>,,PD50,mg kg-1,,19.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,19.0
17359,,,326706,[],CHEMBL634557,Percent of drug absorbed by human intestine after oral administration,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1133113,J Med Chem,2000.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,233449,=,1,0,=,,FA,%,,69.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,FA,%,UO_0000187,,69.0
17360,,,339547,[],CHEMBL808149,Antibacterial activity determined against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136237,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,208166,=,1,1,=,,MIC,nM,,750.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.75
17361,,,339548,[],CHEMBL674721,Antibacterial activity determined against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136237,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,208166,=,1,1,=,,MIC,nM,,750.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.75
17362,,,339549,[],CHEMBL848307,Minimum inhibitory concentration required against bacterial transcription/translation,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136237,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,208166,>,1,1,>,,MIC,nM,,100000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,uM,UO_0000065,,100.0
17363,,,344223,[],CHEMBL677914,Compound was tested for inhibition of the gram-negative organism Escherichia cloacae HA 2646,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
17364,,,344224,[],CHEMBL676843,Compound was tested for inhibition of the gram-negative organism Escherichia coli vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
17365,,,344225,[],CHEMBL676842,Compound was tested for inhibition of the gram-negative organism Escherichia coli H560,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
17366,,,344226,[],CHEMBL700551,Compound was tested for inhibition of the gram-negative organism Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
17367,,,344227,[],CHEMBL767622,Compound was tested for inhibition of the gram-negative organism Providencia rettgeri H1771,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.1
17368,,,344228,[],CHEMBL764329,Compound was tested for inhibition of the gram-negative organism Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
17369,,,344229,[],CHEMBL813313,Compound was tested for inhibition of the gram-negative organism Streptococcus aureus H228.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
17370,,,344230,[],CHEMBL813314,Compound was tested for inhibition of the gram-negative organism Streptococcus aureus UC-76.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17371,,,344231,[],CHEMBL808164,Compound was tested for inhibition of the gram-negative organism Streptococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
17372,,,344232,[],CHEMBL810959,Compound was tested for inhibition of the gram-negative organism Streptococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
17373,,,344233,[],CHEMBL810790,Compound was tested for inhibition of the gram-negative organism Streptococcus pyogenes C203.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
17374,,,344234,[],CHEMBL741709,Compound was evaluated for protective dose against the Escherichia coli vogel lethal infection following peroral administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,268924,=,1,0,=,,PD50,mg kg-1,,1.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.2
17375,,,344235,[],CHEMBL742298,Compound was evaluated for protective dose against the Escherichia coli vogel lethal infection following sc administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,268924,=,1,0,=,,PD50,mg kg-1,,0.25,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.25
17376,,,344236,[],CHEMBL742299,Compound was evaluated for protective dose against the Streptococcus aureus UC-76 lethal infection following po administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,268924,=,1,0,=,,PD50,mg kg-1,,9.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,9.5
17377,,,344237,[],CHEMBL742301,Compound was evaluated for protective dose against the Streptococcus aureus UC-76 lethal infection following sc administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,268924,=,1,0,=,,PD50,mg kg-1,,3.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,3.0
17378,,,344238,[],CHEMBL742303,Compound was evaluated for protective dose against the Streptococcus pneumoniae SV-1 lethal infection following po administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,268924,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
17379,,,344239,[],CHEMBL878067,Compound was evaluated for protective dose against Streptococcus pneumoniae SV-1 lethal infection following sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,268924,=,1,0,=,,PD50,mg kg-1,,18.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,18.0
17380,,,344240,[],CHEMBL686749,Inhibition of DNA gyrase of Escherichia coli H560 cells,B,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268924,=,1,0,=,,Min concentration,ug ml-1,,0.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,Min concentration,ug ml-1,UO_0000274,,0.5
17381,,,345109,[],CHEMBL812128,Minimum inhibitory concentration against Staphylococcus aureus - methicillin resistant Ciprofloxacin sensitive strain MI300,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230790,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17382,,,345110,[],CHEMBL812127,"Minimum inhibitory concentration against Staphylococcus aureus - methicillin resistant Ciprofloxacin resistant, strain MI339",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230790,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
17383,,,345111,[],CHEMBL810065,"Minimum inhibitory concentration against Streptococcus pneumoniae - penicillin sensitive, strain STP64",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230790,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
17384,,,345112,[],CHEMBL811464,"Minimum inhibitory concentration against Streptococcus pneumoniae - penicillin resistant, strain STP51",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230790,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
17385,,,345113,[],CHEMBL879557,"Minimum inhibitory concentration against Escherichia coli, strain ES142",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230790,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17386,,,345114,[],CHEMBL765956,"Minimum inhibitory concentration against Pseudomonas aeruginosa, strain PS96",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230790,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
17387,,,345115,[],CHEMBL686742,Inhibition of Wild Type DNA gyrase Supercoiling Activity in Escherichia coli,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230790,=,1,1,=,,IC50,ug.mL-1,,1.6,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,1.6
17388,,,345116,[],CHEMBL686741,Inhibition of Quinolone resistant gyrase Supercoiling Activity in Escherichia coli,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1145050,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230790,=,1,1,=,,IC50,ug.mL-1,,102.4,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,102.4
17389,,,360612,[],CHEMBL804048,Antibacterial activity carried out in vitro against Staphylococcus aureus VGH 84-47,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
17390,,,360613,[],CHEMBL804046,Antibacterial activity carried out in vitro against Staphylococcus aureus K82-26,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17391,,,360614,[],CHEMBL804047,Antibacterial activity carried out in vitro against Staphylococcus aureus Smith(MP),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
17392,,,360615,[],CHEMBL804851,Antibacterial activity carried out in vitro against Streptococcus faecalis UCI 85-30,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
17393,,,360616,[],CHEMBL804045,Antibacterial activity carried out in vitro against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
17394,,,360617,[],CHEMBL672558,Antibacterial activity carried out in vitro against Escherichia coli MOR 84-20,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17395,,,360618,[],CHEMBL705219,Antibacterial activity carried out in vitro against Klebsiella pneumoniae CMC 84-31,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
17396,,,360619,[],CHEMBL675820,Antibacterial activity carried out in vitro against Enterobacter cloacae VHG 84-39,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
17397,,,360620,[],CHEMBL807529,Antibacterial activity carried out in vitro against Serratia marcescens MOR 84-41,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.008
17398,,,360621,[],CHEMBL753896,Antibacterial activity carried out in vitro against Pseudomonas aeruginosa K84-16,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
17399,,,360622,[],CHEMBL672557,Antibacterial activity carried out in vitro against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
17400,,,360623,[],CHEMBL672554,Antibacterial activity carried out in vitro against Escherichia coli #311(MP),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124495,J Med Chem,1989.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36275,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17401,,,362247,[],CHEMBL676433,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
17402,,,362248,[],CHEMBL676434,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain ATCC 35218,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
17403,,,362249,[],CHEMBL676435,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain DRCC 091,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
17404,,,362250,[],CHEMBL676436,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain DRCC 133,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
17405,,,362251,[],CHEMBL676437,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain DRCC 134,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
17406,,,362252,[],CHEMBL700148,Compound was evaluated for in vitro antibacterial activity against gram negative organism Klebsiella pneumoniae strain ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
17407,,,362253,[],CHEMBL700149,Compound was evaluated for in vitro antibacterial activity against gram negative organism Klebsiella pneumoniae strain DRCC 132,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
17408,,,362254,[],CHEMBL700150,Compound was evaluated for in vitro antibacterial activity against gram negative organism Klebsiella pneumoniae strain DRCC 136,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
17409,,,362255,[],CHEMBL768289,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas fluorescence strain NCIMB 10586,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,8.0
17410,,,362256,[],CHEMBL768288,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas fluorescence strain DRCC 008,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,0.5
17411,,,362257,[],CHEMBL766460,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strains ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
17412,,,362258,[],CHEMBL766459,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strain MTCC 1688,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
17413,,,362259,[],CHEMBL768168,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strain DRCC 131,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
17414,,,362260,[],CHEMBL768340,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strain DRCC 135,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
17415,,,362261,[],CHEMBL766458,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strain DRCC 137,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
17416,,,362262,[],CHEMBL803174,Compound was evaluated for in vitro antibacterial activity against gram negative organism Salmonella abony strain NCIM 2257,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613765,Salmonella enterica subsp. enterica serovar Abony,Salmonella enterica subsp. enterica serovar Abony,29482.0,,,MIC,ug ml-1,UO_0000274,,1.0
17417,,,362263,[],CHEMBL799646,Compound was evaluated for in vitro antibacterial activity against gram negative organism Salmonella typhi strain MTCC 531,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,0.25
17418,,,362264,[],CHEMBL803308,Compound was evaluated for in vitro antibacterial activity against gram negative organism Salmonella Typhimurium MTCC 98,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
17419,,,362265,[],CHEMBL810111,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17420,,,362266,[],CHEMBL810108,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
17421,,,362267,[],CHEMBL810109,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain ATCC 33591,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17422,,,362268,[],CHEMBL810110,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain ATCC 33592,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
17423,,,362269,[],CHEMBL810113,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain MTCC 737,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17424,,,362270,[],CHEMBL813165,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus epidermidis strain ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
17425,,,362271,[],CHEMBL813267,Compound was evaluated for in vitro antibacterial activity against gram positive organism Streptococcus faecalis strain ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.125
17426,,,362272,[],CHEMBL813268,Compound was evaluated for in vitro antibacterial activity against gram positive organism Streptococcus faecalis strain ATCC 49384,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
17427,,,362273,[],CHEMBL813269,Compound was evaluated for in vitro antibacterial activity against gram positive organism Streptococcus faecalis strain ATCC 51299,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
17428,,,362274,[],CHEMBL882264,Compound was evaluated for in vitro antibacterial activity against gram positive organism Streptococcus pyogenes strain DRCC 092,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292693,=,1,1,=,,MIC,ug.mL-1,,0.0015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.0015
17429,,,363721,[],CHEMBL652778,In vitro activity against Bacteroides fragilis (105AT25285),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,4.0
17430,,,363722,[],CHEMBL652779,In vitro activity against Bacteroides fragilis (784),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,4.0
17431,,,363723,[],CHEMBL652783,In vitro activity against Bacteroides fragilis (UC-2),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,4.0
17432,,,363724,[],CHEMBL652780,In vitro activity against Bacteroides fragilis (SFM2906A),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,4.0
17433,,,363725,[],CHEMBL652782,In vitro activity against Bacteroides fragilis (SFM2975-7),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,8.0
17434,,,363726,[],CHEMBL652781,In vitro activity against Bacteroides fragilis (SFM2929-1),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,8.0
17435,,,363727,[],CHEMBL652932,In vitro activity against Bacteroides thetaiotaomicron (SFM2975-2),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,16.0
17436,,,363728,[],CHEMBL651589,In vitro activity against Bacteroides vulgatus(792),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,8.0
17437,,,363729,[],CHEMBL651590,In vitro activity against Bacteroides vulgatus(SFBC 2375),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,8.0
17438,,,363730,[],CHEMBL649662,In vitro activity against Bacteroides disiens (ATCC 29426),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,,MIC,ug ml-1,UO_0000274,,2.0
17439,,,363731,[],CHEMBL876545,In vitro activity against Bacteroides thetaiotaomicron (ATCC 29742),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,16.0
17440,,,363732,[],CHEMBL652934,In vitro activity against Bacteroides thetaiotaomicron (106),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,16.0
17441,,,363733,[],CHEMBL652070,In vitro activity against thetaiotaomicron (ATCC 29741),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,32.0
17442,,,363734,[],CHEMBL859347,In vitro activity against Bacteroides melaninogenicus (ATCC 25845).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC,ug ml-1,UO_0000274,,2.0
17443,,,363735,[],CHEMBL652918,In vitro activity against Bacteroides loescheii (ATCC 15930).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,,MIC,ug ml-1,UO_0000274,,8.0
17444,,,363736,[],CHEMBL648879,In vitro activity against t Bacteroides bivius(B 6140),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC,ug ml-1,UO_0000274,,2.0
17445,,,363737,[],CHEMBL681397,In vitro activity against Fusobacterium nucleatum (ATCC 25586),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,4.0
17446,,,363738,[],CHEMBL678322,In vitro activity against Fusobacterium sp.(GS-10),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614608,Fusobacterium,Fusobacterium,848.0,,,MIC,ug ml-1,UO_0000274,,4.0
17447,,,363739,[],CHEMBL820804,In vitro activity against Veillonella parvula (ATCC 10790),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612244,Veillonella parvula,Veillonella parvula,29466.0,,,MIC,ug ml-1,UO_0000274,,0.25
17448,,,363740,[],CHEMBL659020,In vitro activity against Clostridium perfringens (104AT13124),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.5
17449,,,363741,[],CHEMBL659022,In vitro activity against Clostridium perfringens (SFBC 2026),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,2.0
17450,,,363742,[],CHEMBL659021,In vitro activity against Clostridium perfringens (788),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.5
17451,,,363743,[],CHEMBL657488,In vitro activity against Clostridium difficile (ATCC 9689),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
17452,,,363744,[],CHEMBL660124,In vitro activity against Clostridium difficile (ATCC 17857),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
17453,,,363745,[],CHEMBL660465,In vitro activity against Clostridium romosum (7),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC,ug ml-1,UO_0000274,,8.0
17454,,,363746,[],CHEMBL769562,In vitro activity against Propionibacterium acnes (132),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,2.0
17455,,,363747,[],CHEMBL765431,In vitro activity against Peptococcus asaccharolyticus (ATCC 14963).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,2.0
17456,,,363748,[],CHEMBL765436,In vitro activity against Peptococcus magnus (ATCC 29328),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC,ug ml-1,UO_0000274,,0.25
17457,,,363749,[],CHEMBL765445,In vitro activity against Peptostreptococcus sp.(TB-11),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614418,Peptostreptococcus,Peptostreptococcus,1257.0,,,MIC,ug ml-1,UO_0000274,,2.0
17458,,,363750,[],CHEMBL760159,In vitro activity against Peptostreptococcus micros (ATCC 33270),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC,ug ml-1,UO_0000274,,0.5
17459,,,363751,[],CHEMBL764399,In vitro activity against Peptostreptococcus anaerobius (ATCC 27337),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65572,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,2.0
17460,,,363752,[],CHEMBL738377,"In vivo activity against Pseudomonas aeruginosa A5007 (100X LD50), administered sc ( each compound tested at 3 doses with 10 animals)",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,65572,=,1,1,=,,ED50,mg.kg-1,,4.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,4.1
17461,,,363753,[],CHEMBL738376,"In vivo activity against Pseudomonas aeruginosa A5007 (100X LD50), administered po( each compound tested at 3 doses with 10 animals)",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,65572,=,1,1,=,,ED50,mg.kg-1,,15.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,15.1
17462,,,363754,[],CHEMBL738374,"In vivo activity against Escherichia coli Juhl(100X LD50), when administered sc( each compound tested at 3 doses with 10 animals)",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,65572,=,1,1,=,,ED50,mg.kg-1,,0.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,0.3
17463,,,363755,[],CHEMBL738372,"In vivo activity against Escherichia coli Juhl(100X LD50), when administered po( each compound tested at 3 doses with 10 animals)",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,65572,=,1,1,=,,ED50,mg.kg-1,,1.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,1.3
17464,,,365410,[],CHEMBL687257,Gyrase inhibitory activity against Escherichia coli,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,76484,=,1,1,=,,IC50,ug.mL-1,,0.3,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,IC50,ug ml-1,UO_0000274,,0.3
17465,,,365411,[],CHEMBL674480,In vitro minimum inhibitory concentration against Escherichia coli (ATCC 1-25922),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,76484,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
17466,,,365412,[],CHEMBL763973,In vitro minimum inhibitory concentration against Pseudomonas aeruginosa (ATCC 27853),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,76484,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
17467,,,365413,[],CHEMBL883624,In vitro minimum inhibitory concentration against Staphylococcus aureus (ATCC 29213),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,76484,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17468,,,365414,[],CHEMBL811548,In vitro minimum inhibitory concentration against Streptococcus faecalis (ATCC 29212),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,76484,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17469,,,365415,[],CHEMBL812253,In vitro minimum inhibitory concentration against Streptococcus pneumoniae (ATCC 6301),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,76484,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
17470,,,365416,[],CHEMBL648904,In vitro minimum inhibitory concentration against Bacteroides fragilis (ATCC 25285),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,76484,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,2.0
17471,,,365417,[],CHEMBL857252,In vivo antibacterial activity against Escherichia coli (Vogel) in mice administered subcutaneously,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,76484,=,1,0,=,,PD50,mg kg-1,,0.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.2
17472,,,365418,[],CHEMBL738934,In vivo antibacterial activity against Escherichia coli (Vogel) in mice administered perorally,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124193,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,76484,=,1,0,=,,PD50,mg kg-1,,0.86,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.86
17473,,,369758,[],CHEMBL812283,Inhibitory activity against HeLa cell Topoisomerase II,B,,,BAO_0000188,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128887,Bioorg Med Chem Lett,1995.0,"{'bei': '22.70', 'le': '0.43', 'lle': '5.94', 'sei': '10.09'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,7.52,0,http://www.openphacts.org/units/Nanomolar,2875,=,1,1,=,,EC50,nM,,30.0,CHEMBL2094255,Homo sapiens,DNA topoisomerase II,9606.0,,,EC50,uM,UO_0000065,,0.03
17474,,,392265,[],CHEMBL809926,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 13N Munchen,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
17475,,,392266,[],CHEMBL882256,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 48N Munchen,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
17476,,,392267,[],CHEMBL809941,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 90 Innsbruck,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
17477,,,392268,[],CHEMBL809938,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 77 Innsbruck,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
17478,,,392269,[],CHEMBL809937,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 4978 Israel,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,<=,1,1,<=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
17479,,,392270,[],CHEMBL858242,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 17N Munchen,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
17480,,,392271,[],CHEMBL809939,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 79B Innsbruck,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
17481,,,392272,[],CHEMBL809940,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 86 Innsbruck,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
17482,,,392273,[],CHEMBL809936,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 41h Belgium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
17483,,,392274,[],CHEMBL809928,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 21b Belgium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
17484,,,392275,[],CHEMBL809927,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 1756,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,<=,1,1,<=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
17485,,,392276,[],CHEMBL809932,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 25464,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,<=,1,1,<=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
17486,,,392277,[],CHEMBL809934,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 25697,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
17487,,,392278,[],CHEMBL809935,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 25768,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
17488,,,392279,[],CHEMBL809931,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 25463,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
17489,,,392280,[],CHEMBL809933,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 25470,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,<=,1,1,<=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
17490,,,392281,[],CHEMBL809929,Minimum inhibitory concentration required for the antibacterial activity against Staphylococcus aureus 25085,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125330,<=,1,1,<=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
17491,,,407360,[],CHEMBL678390,In vitro antibacterial activity against Enterococcus faecalis A9809,A,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg l-1,UO_0000274,,0.5
17492,,,407361,[],CHEMBL679459,In vitro antibacterial activity against Enterococcus faecium A 24885.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,mg l-1,UO_0000274,,4.0
17493,,,407362,[],CHEMBL810321,In vitro antibacterial activity against Staphylococcus aureus A9537.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg l-1,UO_0000274,,0.06
17494,,,407363,[],CHEMBL680459,In vitro antibacterial activity against Escherichia coli A 15119.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg l-1,UO_0000274,,0.006
17495,,,407364,[],CHEMBL704962,In vitro antibacterial activity against Klebsiella pneumoniae A 9664.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg l-1,UO_0000274,,0.06
17496,,,407365,[],CHEMBL678586,In vitro antibacterial activity against Enterobacter cloacae A 9656.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,mg l-1,UO_0000274,,0.03
17497,,,407366,[],CHEMBL732709,In vitro antibacterial activity against Morganella morganii A 15153.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,mg l-1,UO_0000274,,0.06
17498,,,407367,[],CHEMBL802086,In vitro antibacterial activity against Serratia marcescens A 20019.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,mg l-1,UO_0000274,,0.03
17499,,,407368,[],CHEMBL771576,In vitro antibacterial activity against Pseudomonas aeruginosa A 9243.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257494,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg l-1,UO_0000274,,0.25
17500,,,407369,[],CHEMBL808064,In vivo potency on systemic infection caused by Staphylococcus aureus A9537 after oral administration to mice expressed as median protective dose.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,PD50,mg kg-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,4.0
17501,,,407370,[],CHEMBL772679,In vivo potency on systemic infection caused by after oral administration to mice expressed as median protective dose.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,PD50,mg kg-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,5.0
17502,,,407371,[],CHEMBL676460,In vivo potency on systemic infection caused by after oral administration to mice expressed as median protective dose.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,PD50,mg kg-1,,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.7
17503,,,407372,[],CHEMBL700897,In vivo potency on systemic infection caused by after oral administration to mice expressed as median protective dose.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,PD50,mg kg-1,,1.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,PD50,mg kg-1,UO_0000308,,1.5
17504,,,407373,[],CHEMBL740237,Acute toxicity with oral administration in OF1 strain female swiss mice.,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,LD50,po,,5000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,po,,,5000.0
17505,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,407374,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL632166,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,257494,=,1,1,=,,Cmax,nM,,17805.95,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,5.9
17506,,,407375,[],CHEMBL635298,Pharmacokinetic property (t1/2- Plasma half life of the compound) after oral administration in mice (50 mg/kg).,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,257494,=,1,1,=,,T1/2,hr,,0.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T1/2,hr,UO_0000032,,0.9
17507,,,407376,[],CHEMBL622222,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,AUC,,,7.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,,,,7.0
17508,,,407377,[],CHEMBL638294,Pharmacokinetic property(UR- urinary recovery after 24 hours (percent of administered dose)) after oral administration in mice (50 mg/kg).,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,UR,,,29.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,UR,,,,29.0
17509,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,407378,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL632165,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,257494,=,1,1,=,,Cmax,nM,,9053.87,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,Cmax,ug ml-1,UO_0000065,,3.0
17510,,,407379,[],CHEMBL635297,Pharmacokinetic property (t1/2- Plasma half life of the compound) after oral administration in dog (25 mg/kg).,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,257494,=,1,1,=,,T1/2,hr,,3.5,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,T1/2,hr,UO_0000032,,3.5
17511,,,407380,[],CHEMBL622221,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,AUC,,,20.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,AUC,,,,20.0
17512,,,407381,[],CHEMBL876914,Pharmacokinetic property(UR- urinary recovery after 24 hours (percent of administered dose)) after oral administration in dog (25 mg/kg).,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126257,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257494,=,1,0,=,,UR,,,17.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,UR,,,,17.0
17513,,,413142,[],CHEMBL683837,In vitro antiviral activity against HIV-1 IIIB in C8166 (human CD4) cells.,F,,,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1133686,J Med Chem,2000.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.0,0,http://www.openphacts.org/units/Nanomolar,237882,=,1,1,=,,EC50,nM,,100000.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676.0,,,EC50,uM,UO_0000065,,100.0
17514,,,413143,[],CHEMBL695376,In vitro toxicity to C8166 (human CD4) cells.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1133686,J Med Chem,2000.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,237882,=,1,0,=,,TC50,uM,,160.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676.0,,,TC50,uM,UO_0000064,,160.0
17515,,,413144,[],CHEMBL654123,Selectivity index in HIV-1 infected C8166 (human CD4) cells.,F,,,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1133686,J Med Chem,2000.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,237882,=,1,0,=,,SI,,,1.6,CHEMBL614533,Homo sapiens,C8166,9606.0,,,SI,,,,1.6
17516,,,424297,[],CHEMBL801729,Tested in vitro against Staphylococcus aureus FDA209P JC-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17517,,,424298,[],CHEMBL805357,Tested in vitro against Staphylococcus epidermidis IAM12896 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.56
17518,,,424299,[],CHEMBL651227,Tested in vitro against Bacillus subtilis ATCC 6633 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.1
17519,,,424300,[],CHEMBL681533,Tested in vitro against Escherichia coli NIHJ JC-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
17520,,,424301,[],CHEMBL703026,Tested in vitro against Klebsiella pneumoniae PCI-602 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.025
17521,,,424302,[],CHEMBL767454,Tested in vitro against Proteus vulgaris OX-19 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.05
17522,,,424303,[],CHEMBL800637,Tested in vitro against Salmonella Typhimurium IID971 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.025
17523,,,424304,[],CHEMBL882145,Tested in vitro against Serratia marcescens IAM1184 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.39
17524,,,424305,[],CHEMBL753900,Tested in vitro against Pseudomonas aeruginosa IFO3445 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
17525,,,424306,[],CHEMBL801730,Tested in vitro against Staphylococcus aureus IID803 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
17526,,,424307,[],CHEMBL801728,Tested in vivo against Staphylococcus aureus IID803 in mice after peroral dose of drug with 0.5% sodium carboxy methyl cellulose,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,167702,=,1,1,=,,ED50,mg.kg-1,,35.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,35.4
17527,,,424308,[],CHEMBL883414,Tested in vitro against Pseudomonas aeruginosa E-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167702,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
17528,,,424309,[],CHEMBL753895,Tested in vivo against Pseudomonas aeruginosa E-2 in mice after peroral dose of drug with 0.5% sodium carboxy methyl cellulose,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,167702,=,1,1,=,,ED50,mg.kg-1,,30.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,30.8
17529,,,430846,[],CHEMBL652544,Antibacterial activity against Bacillus subtilis was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144871,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,169377,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.078
17530,,,430847,[],CHEMBL807196,Antibacterial activity against Staphylococcus aureus was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144871,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,169377,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.156
17531,,,430848,[],CHEMBL807197,Antibacterial activity against Staphylococcus aureus(smith) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144871,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,169377,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.078
17532,,,430849,[],CHEMBL810597,Antibacterial activity against methicillin-resistant strain of Staphylococcus aureus(MRSA B42876) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144871,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,169377,>,1,1,>,,MIC,ug.mL-1,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,20.0
17533,,,430850,[],CHEMBL674281,Antibacterial activity against Enterococcus faecalis was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144871,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,169377,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.625
17534,,,430851,[],CHEMBL674284,Antibacterial activity against Enterococcus faecium was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144871,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,169377,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,5.0
17535,,,430852,[],CHEMBL674282,Antibacterial activity against vancomycin-resistant strain of Enterococcus faecalis(VRE) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144871,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,169377,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,20.0
17536,,,430853,[],CHEMBL675390,Antibacterial activity against Escherichia coli was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144871,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,169377,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.313
17537,,,444855,[],CHEMBL805541,Antibacterial activity against Staphylococcus aureus NCTC-10649M was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17538,,,444856,[],CHEMBL807354,Antibacterial activity against Staphylococcus aureus A1775 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
17539,,,444857,[],CHEMBL674673,Antibacterial activity against Enterococcus faecium ATCC 8043 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.78
17540,,,444858,[],CHEMBL810217,Antibacterial activity against Gram-positive Streptococcus bovis A5169 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,0.78
17541,,,444859,[],CHEMBL808695,Antibacterial activity against Streptococcus pyogenes EES61 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.78
17542,,,444860,[],CHEMBL678479,Antibacterial activity against Escherichia coli JUHL was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
17543,,,444861,[],CHEMBL679920,Antibacterial activity against Enterobacter aerogenes ATCC 13048 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.02
17544,,,444862,[],CHEMBL703086,Antibacterial activity against Klebsiella pneumoniae ATCC 8045 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.02
17545,,,444863,[],CHEMBL767523,Antibacterial activity against Gram-negative Providencia Stuartii CMX640 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,MIC,ug ml-1,UO_0000274,,1.56
17546,,,444864,[],CHEMBL771953,Antibacterial activity against Pseudomonas aeruginosa A-5007 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17547,,,444865,[],CHEMBL686756,Compound was tested for bacterial DNA gyrase activity,B,,,BAO_0000187,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,101783,=,1,1,=,,CC50,ug.mL-1,,0.24,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,CC50,ug ml-1,UO_0000274,,0.24
17548,,,444866,[],CHEMBL716477,Compound was tested for its effective dose against Staphylococcus aureus NCTC-10649M in mice upon subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,101783,=,1,0,=,,ED50,mg kg-1 day-1,,4.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1 day-1,UO_0000311,,4.1
17549,,,444867,[],CHEMBL716476,Compound was tested for its effective dose against Staphylococcus aureus NCTC-10649M in mice upon peroral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,101783,=,1,0,=,,ED50,mg kg-1 day-1,,28.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1 day-1,UO_0000311,,28.2
17550,,,444868,[],CHEMBL717371,Effective dose against Escherichia coli JUHL in mice upon subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,101783,=,1,0,=,,ED50,mg kg-1 day-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1 day-1,UO_0000311,,0.1
17551,,,444869,[],CHEMBL717890,Compound was tested for its effective dose against Escherichia coli JUHL in mice upon peroral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,101783,=,1,0,=,,ED50,mg kg-1 day-1,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1 day-1,UO_0000311,,1.0
17552,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,444870,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL627784,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,101783,=,1,1,=,,Cmax,nM,,452.69,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,0.15
17553,,,444871,[],CHEMBL622278,Oral bioavailability in rat (dose 5 mg/kg),A,,,BAO_0003042,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130900,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,101783,=,1,1,=,,F,%,,16.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,F,%,UO_0000187,,16.0
17554,,,466197,[],CHEMBL804635,Antibacterial activity against staphylococcus aureus ATCC 25923 was determined after 24 hr,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145806,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,161530,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
17555,,,466198,[],CHEMBL673728,Antibacterial activity against enteropathogenic Escherichia coli ATCC 25922 was determined after 24 hr,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145806,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,161530,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
17556,,,466199,[],CHEMBL764314,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 was determined after 24 hr,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145806,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,161530,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
17557,,,504617,[],CHEMBL676313,Antibacterial activity against Escherichia coli MTCC 42 measured through zone of inhibition; 21-25 mm,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146814,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Millimolar,239098,=,1,0,=,,Zone of inhibition,mM,,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Zone of inhibition,mM,UO_0000063,,21.0
17558,,,504618,[],CHEMBL805065,Antibacterial activity against Staphylococcus aureus MTCC 1430 measured through zone of inhibition; 21-25 mm,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146814,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Millimolar,239098,=,1,0,=,,Zone of inhibition,mM,,21.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Zone of inhibition,mM,UO_0000063,,21.0
17559,,,504619,[],CHEMBL767641,Antibacterial activity against Pseudomonas aeruginosa MTCC 1034. measured through zone of inhibition; 16-20 mm,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146814,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Millimolar,239098,=,1,0,=,,Zone of inhibition,mM,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Zone of inhibition,mM,UO_0000063,,16.0
17560,,,504620,[],CHEMBL649463,Antibacterial activity against Bacillus cereus MTCC 1272 measured through zone of inhibition; 16-20 mm,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146814,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Millimolar,239098,=,1,0,=,,Zone of inhibition,mM,,16.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,Zone of inhibition,mM,UO_0000063,,16.0
17561,,,504621,[],CHEMBL650452,Antibacterial activity against Bacillus subtilis MTCC 121 measured through zone of inhibition; 21-25 mm,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146814,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Millimolar,239098,=,1,0,=,,Zone of inhibition,mM,,21.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Zone of inhibition,mM,UO_0000063,,21.0
17562,,,511597,[],CHEMBL882606,Inhibitory concentration against Staphylococcus aureus; Not active,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148348,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223086,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.1
17563,,,511598,[],CHEMBL805611,Inhibitory concentration against methicillin-resistant Staphylococcus aureus,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148348,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223086,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.1
17564,,Not Determined,511599,[],CHEMBL663620,Inhibitory concentration against Cryptococcus neoformans; Not tested,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148348,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223086,,1,0,,,IC50,ug.mL-1,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,IC50,ug ml-1,UO_0000274,,
17565,,,511600,[],CHEMBL747264,Inhibitory concentration against Mycobacterium intracellular,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148348,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223086,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,ug ml-1,UO_0000274,,0.25
17566,,Not Determined,511601,[],CHEMBL689152,Effective concentration against HIV-1; Not tested,F,,,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148348,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,223086,,1,0,,,EC50,nM,,,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676.0,,,EC50,uM,UO_0000065,,
17567,,,568771,[],CHEMBL846966,Fold reduction in minimum inhibitory concentration of antibiotic in presence of Reserpine,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146678,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,336905,=,1,0,=,,Fold_reduction,,,8.0,CHEMBL612545,,Unchecked,,,,Fold_reduction,,,,8.0
17568,,,568772,[],CHEMBL846845,Fold reduction in minimum inhibitory concentration of antibiotic in presence of GG918,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146678,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,336905,=,1,0,=,,Fold_reduction,,,8.0,CHEMBL612545,,Unchecked,,,,Fold_reduction,,,,8.0
17569,,,587036,[],CHEMBL682684,Compound evaluated in vitro against five gram-negative bacterial strains and geometric means of the minimum inhibitory concentrations (MIC) reported.,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125245,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,311902,=,1,0,=,,MIC,,,0.06,CHEMBL612545,,Unchecked,,,,MIC,,,,0.06
17570,,,587037,[],CHEMBL680233,Compound evaluated in vitro against five gram-positive bacterial strains and geometric means of the minimum inhibitory concentrations (MIC) reported.,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125245,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,311902,=,1,0,=,,MIC,,,0.91,CHEMBL612545,,Unchecked,,,,MIC,,,,0.91
17571,,,587038,[],CHEMBL657329,Compound evaluated in vitro for the ability to inhibit gyrase.,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125245,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,311902,=,1,1,=,,IC50,ug.mL-1,,5.3,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,I50,ug ml-1,UO_0000274,,5.3
17572,,,587039,[],CHEMBL676461,In vivo protection against gram-positive Escherichia coli vogel in mouse after oral administration.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125245,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,311902,=,1,0,=,,PD50,mg kg-1,,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.2
17573,,,587040,[],CHEMBL676304,In vivo protection against gram-positive Escherichia coli vogel in mouse after subcutaneous administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125245,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,311902,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.3
17574,,,587041,[],CHEMBL812951,In vivo protection against gram-positive Streptococcus pneumonia (SV-1) in mouse after oral administration.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125245,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,311902,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,100.0
17575,,,587042,[],CHEMBL812952,In vivo protection against gram-positive Streptococcus pneumonia (SV-1) in mouse after subcutaneous administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125245,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,311902,=,1,0,=,,PD50,mg kg-1,,29.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,29.0
17576,,,591622,[],CHEMBL808027,In vitro antibacterial activity against ciprofloxacin and oxazolidinone Linezolid resistant Staphylococcus aureus ATCC 29213 (Saul),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,258364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17577,,,591623,[],CHEMBL809453,In vitro antibacterial activity against ciprofloxacin and methicillin resistant Staphylococcus aureus (Sau2CIP) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,258364,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
17578,,,591624,[],CHEMBL810369,In vitro antibacterial activity against oxazolidinone Linezolid resistant Staphylococcus aureus (Sau3LZD) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,258364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17579,,,591625,[],CHEMBL674689,In vitro antibacterial activity against Enterococcus faecalis ATCC 29212 (Efs) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,258364,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
17580,,,591626,[],CHEMBL674656,In vitro antibacterial activity against vancomycin and ciprofloxacin resistant Enterococcus faecium (Efm CIP) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,258364,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,32.0
17581,,,591627,[],CHEMBL857212,In vitro antibacterial activity against Haemophilus influenzae 11 (Hin) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,258364,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
17582,,,591628,[],CHEMBL679690,In vitro antibacterial activity against Escherichia coli ATCC 25922 (Ecol) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,258364,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
17583,,,591629,[],CHEMBL878429,"In vitro antibacterial activity against Escherichia coli AS19 (Eco2), permeable mutant was determined",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,258364,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
17584,,,591630,[],CHEMBL657999,Inhibitory activity against DNA gyrase enzyme was determined by supercoiling assay with Escherichia coli DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,"{'bei': '19.02', 'le': '0.36', 'lle': '4.72', 'sei': '8.45'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.3,0,http://www.openphacts.org/units/Nanomolar,258364,=,1,1,=,,IC50,nM,,500.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.5
17585,,,591631,[],CHEMBL809381,Inhibitory activity against Escherichia coli Topoisomerase IV in relaxation assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.6,0,http://www.openphacts.org/units/Nanomolar,258364,=,1,1,=,,IC50,nM,,2500.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,2.5
17586,,,591632,[],CHEMBL678817,In vitro inhibitory activity against protein synthesis was determined by transcription/translation assay with Escherichia coli S30 Extract System.,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146637,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,258364,>,1,1,>,,IC50,nM,,20000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,uM,UO_0000065,,20.0
17587,,,596363,[],CHEMBL858623,The compound was tested for its antimicrobial activity against Staphylococcus aureus ATCC 6538P (Sa(A)) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17588,,,596364,[],CHEMBL810469,The compound was tested for its antimicrobial activity against Staphylococcus aureus CMX 68613 (Sa) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17589,,,596365,[],CHEMBL806196,The compound was tested for its antimicrobial activity against Staphylococcus epidermidis 3519 (Se) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.2
17590,,,596366,[],CHEMBL811315,The compound was tested for its antimicrobial activity against Streptococcus faecium ATCC 8043 (Sf) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.39
17591,,,596367,[],CHEMBL809709,The compound was tested for its antimicrobial activity against Streptococcus pyogenes 930 (Sp) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.39
17592,,,596368,[],CHEMBL676923,The compound was tested for its antimicrobial activity against Escherichia coli juhl (Ec) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
17593,,,596369,[],CHEMBL859366,The compound was tested for its antimicrobial activity against Enterobacter aerogenes ATCC 13048 (Ea) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.05
17594,,,596370,[],CHEMBL701262,The compound was tested for its antimicrobial activity against Klebsiella pneumoniae 8045 (Kp) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.01
17595,,,596371,[],CHEMBL771543,The compound was tested evaluated for its antimicrobial activity against Pseudomonas aeruginosa A5007 (Pa(5)) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
17596,,,596372,[],CHEMBL770338,The compound was tested evaluated for its antimicrobial activity against Pseudomonas aeruginosa ( Pa(K)) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.05
17597,,,596373,[],CHEMBL877636,The compound was tested for its antimicrobial activity against Acinetobacter sp. CMX 669 (A) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,3.1
17598,,,596374,[],CHEMBL879975,The compound was tested for its antimicrobial activity against Micrococcus luteus (MI) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,1.56
17599,,,596375,[],CHEMBL727007,The compound was tested for inhibition constant against DNA gyrase isolated from micrococcus luteus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,38.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,38.0
17600,,,596376,[],CHEMBL681148,The compound was tested for inhibition constant against DNA gyrase isolated from Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109442,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.9
17601,,,604313,[],CHEMBL800037,Minimum inhibition concentration against Staphylococcus aureus FDA209P strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17602,,,604314,[],CHEMBL807554,Minimum inhibition concentration against Staphylococcus aureus MRSA strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
17603,,,604315,[],CHEMBL804725,Minimum inhibition concentration against Streptococcus pneumoniae Type I strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.39
17604,,,604316,[],CHEMBL675160,Minimum inhibition concentration against Enterococcus faecalis LS-101 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.39
17605,,,604317,[],CHEMBL672322,Minimum inhibition concentration against Escherichia coli NIHJ JC-2 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
17606,,,604318,[],CHEMBL756153,Minimum inhibition concentration against Pseudomonas aeruginosa U-31 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
17607,,,604319,[],CHEMBL682993,Percentage of GABA-induced chloride currents with compound alone at 10 e-4 M,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,41458,=,1,0,=,,Currents,%,,64.0,CHEMBL2093872,Homo sapiens,GABA-A receptor; anion channel,9606.0,,,Currents,%,UO_0000187,,64.0
17608,,,604320,[],CHEMBL682991,Percentage of GABA-induced chloride currents with 10 e-5 M 4-biphenylacetic acid,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,41458,=,1,0,=,,Currents,%,,0.0,CHEMBL2093872,Homo sapiens,GABA-A receptor; anion channel,9606.0,,,Currents,%,UO_0000187,,0.0
17609,,,604321,[],CHEMBL856170,Inhibition of [3H]muscimol binding to GABA A receptor with compound alone at 10 e-4 M,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,"{'bei': '12.07', 'le': '0.23', 'lle': '2.42', 'sei': '5.36'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.0,0,http://www.openphacts.org/units/Nanomolar,41458,=,1,1,=,,IC50,nM,,100000.0,CHEMBL1907607,Rattus norvegicus,GABA-A receptor; anion channel,10116.0,,,IC50,M,UO_0000065,,0.0001
17610,,,604322,[],CHEMBL681272,Inhibition of [3H]muscimol binding to GABA A receptor 4-biphenylacetic acid at 10 e-4 M,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,"{'bei': '19.28', 'le': '0.36', 'lle': '4.81', 'sei': '8.57'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.39,0,http://www.openphacts.org/units/Nanomolar,41458,=,1,1,=,,IC50,nM,,410.0,CHEMBL1907607,Rattus norvegicus,GABA-A receptor; anion channel,10116.0,,,IC50,M,UO_0000065,,4.1e-07
17611,,,604323,[],CHEMBL716311,Percentage of mice with convulsion with compound alone at 400 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,41458,=,1,0,=,,Convulsion,%,,0.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Convulsion,%,UO_0000187,,0.0
17612,,,604324,[],CHEMBL716310,Percentage of mice with convulsion (400 mg/kg fenbufen),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,41458,=,1,0,=,,Convulsion,%,,63.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Convulsion,%,UO_0000187,,63.0
17613,,,604325,[],CHEMBL804053,Minimum inhibitory concentration against Staphylococcus aureus Smith,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17614,,,604326,[],CHEMBL735951,Effective dose against Staphylococcus aureus smith strain in mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,41458,=,1,0,=,,ED50,mg mouse-1,,0.354,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg mouse-1,,,0.354
17615,,,604327,[],CHEMBL674442,Minimum inhibitory concentration against Escherichia coli KC14 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,<,1,1,<,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
17616,,,604328,[],CHEMBL735950,Effective dose against Escherichia coli KC14 strain in mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,41458,=,1,0,=,,ED50,mg mouse-1,,0.007,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg mouse-1,,,0.007
17617,,,604329,[],CHEMBL636866,Calculated partition coefficient (clogP),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,41458,=,1,1,=,,CLogP,,,0.78,CHEMBL2362975,,No relevant target,,,,clogP,,,,0.78
17618,,,604330,[],CHEMBL636984,The compound was evaluated for the solubility in water at 25 degrees Centigrade,A,,,BAO_0002135,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41458,=,1,1,=,,Solubility,ug.mL-1,,70.0,CHEMBL612558,,ADMET,,,,Solubility,ug ml-1,UO_0000274,,70.0
17619,,,614465,[],CHEMBL673826,In vitro minimal inhibitory concentration against Escherichia coli ATCC 25922 (Ec(A)),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
17620,,,614466,[],CHEMBL673825,In vitro minimal inhibitory concentration against Escherichia coli #311 (Ec(B)),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
17621,,,614467,[],CHEMBL679437,In vitro minimal inhibitory concentration against Enterobacter cloacae VGH-84-39 (Et(c)),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.015
17622,,,614468,[],CHEMBL732720,In vitro minimal inhibitory concentration against Morganella morganii CMC-84-39 (Mn),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.015
17623,,,614469,[],CHEMBL772664,In vitro minimal inhibitory concentration against Pseudomonas aeruginosa 12-4-4 (Pa),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17624,,,614470,[],CHEMBL810584,In vitro minimal inhibitory concentration against Staphylococcus aureus Smith (MP) (Sa(A)),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17625,,,614471,[],CHEMBL810583,In vitro minimal inhibitory concentration against Staphylococcus aureus ATCC 29213 (Sa(B)),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
17626,,,614472,[],CHEMBL882116,In vitro minimal inhibitory concentration Streptococcus faecalis VGH-84 (Sf(V)),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
17627,,,614473,[],CHEMBL814004,In vitro minimal inhibitory concentration against Streptococcus faecalis UCI-85 (Sf(U)),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,52759,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
17628,,,614474,[],CHEMBL674848,Median effective dose against female mice infected with Escherichia coli #311 after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,52759,=,1,1,=,,ED50,mg.kg-1,,0.49,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,0.49
17629,,,614475,[],CHEMBL674849,Median effective dose against female mice infected with Escherichia coli #311 after subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,52759,=,1,1,=,,ED50,mg.kg-1,,0.07,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,0.07
17630,,,614476,[],CHEMBL804040,Median effective dose against female mice infected with Staphylococcus aureus Smith after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,52759,=,1,1,=,,ED50,mg.kg-1,,3.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,3.8
17631,,,614477,[],CHEMBL804041,Median effective dose against female mice infected with Staphylococcus aureus Smith after subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,52759,=,1,1,=,,ED50,mg.kg-1,,0.69,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,0.69
17632,,,614478,[],CHEMBL881366,Ratio of ED50 value of (po/sc) was determined for Escherichia coli #311,F,,,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,52759,=,1,0,=,,Ratio,,,7.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,7.0
17633,,,614479,[],CHEMBL849397,Ratio of ED50 value of (po/sc) was determined for Staphylococcus aureus Smith,F,,,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124927,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,52759,=,1,0,=,,Ratio,,,5.5,CHEMBL612545,,Unchecked,,,,Ratio,,,,5.5
17634,,,614626,[],CHEMBL810964,In vitro antibacterial activity against Streptococcus pneumoniae A 9585,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
17635,,,614627,[],CHEMBL676022,In vitro antibacterial activity against Enterococcus faecalis A 9809,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17636,,,614628,[],CHEMBL811158,"In vitro antibacterial activity (minimum inhibitory concentration, MIC) against Staphylococcus aureus A 9537.",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
17637,,,614629,[],CHEMBL811157,In vitro antibacterial activity against Staphylococcus aureus A 24227,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
17638,,,614630,[],CHEMBL878406,Compound was tested in vitro for its antibacterial activity (minimum inhibitory concentration) against Escherichia coli A 15119 (gram negative).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17639,,,614631,[],CHEMBL704961,In vitro antibacterial activity against Klebsiella pneumoniae A 9664,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
17640,,,614632,[],CHEMBL675789,Compound was tested in vitro for its antibacterial activity (minimum inhibitory concentration) against Enterobacter cloacae A 9656 (gram negative).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
17641,,,614633,[],CHEMBL765703,"In vitro antibacterial activity (minimum inhibitory concentration, MIC) against Proteus mirabilis A 9900",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.008
17642,,,614634,[],CHEMBL732149,In vitro antibacterial activity against Morganella morganii A 15153,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.008
17643,,,614635,[],CHEMBL810636,In vitro antibacterial activity (minimum inhibitory concentration) against Serratia marcescens A 20019.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.03
17644,,,614636,[],CHEMBL764170,"Compound was tested in vitro for its antibacterial activity (minimum inhibitory concentration, MIC) against Pseudomonas aeruginosa A 9843",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17645,,,614637,[],CHEMBL696267,In vitro antibacterial activity against Haemophilus influenzae A 21515,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
17646,,,614638,[],CHEMBL649472,Compound was tested in vitro for its antibacterial activity (minimum inhibitory concentration) against Bacteroides fragilis A 22862.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,4.0
17647,,,614639,[],CHEMBL634774,Compound was tested for its solubility at 20 degrees C and isoelectric pH.,A,,,BAO_0002135,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,232374,=,1,1,=,,Solubility,ug.mL-1,,0.07,CHEMBL612558,,ADMET,,,,S,ug ml-1,UO_0000274,,0.07
17648,,,614640,[],CHEMBL807238,Compound was tested for the dose to protect 50% of mice from lethal infection against Staphylococcus aureus A 9606 after peroral administration to OF1-strain of female Swiss mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,=,1,0,=,,PD50,mg kg-1,,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,31.0
17649,,,614641,[],CHEMBL772794,Compound was tested for the dose to protect 50% of mice from lethal infection against Pseudomonas aeruginosa A9843 after peroral administration to OF1-strain of female Swiss mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,=,1,0,=,,PD50,mg kg-1,,2.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,2.6
17650,,,614642,[],CHEMBL676282,Compound was tested for the dose to protect 50% of mice from lethal infection against Escherichia coli A 15119 after peroral administration to OF1-strain of female Swiss mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,=,1,0,=,,PD50,mg kg-1,,0.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.4
17651,,,614643,[],CHEMBL804538,Compound was tested for the dose to protect 50% of mice from lethal infection against Streptococcus pneumoniae after peroral administration to OF1-strain of female Swiss mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,>,1,0,>,,PD50,mg kg-1,,69.0,CHEMBL612545,,Unchecked,,,,PD50,mg kg-1,UO_0000308,,69.0
17652,,,614644,[],CHEMBL739700,Compound was tested for its acute toxicity after intravenous (iv) administration to OF1-strain of female Swiss mice.,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,=,1,0,=,,LD50,,,273.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,,,,273.0
17653,,,614645,[],CHEMBL739701,Compound was tested for its acute toxicity after peroral(po) administration to OF1-strain of female Swiss mice.,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,=,1,0,=,,LD50,,,5000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,,,,5000.0
17654,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,614646,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL626012,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,232374,=,1,1,=,,Cmax,nM,,18107.74,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,6.0
17655,,,614647,[],CHEMBL639405,Compound was evaluated in vivo in blood samples from the orbital sinus for its half life after 40 mg/kg of peroral administration in mice.,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,232374,=,1,1,=,,T1/2,hr,,0.9333,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T1/2,min,UO_0000032,,56.0
17656,,,614648,[],CHEMBL622559,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,=,1,1,=,,AUC,ng.hr.mL-1,,7000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug ml-1 hr-1,,,7.0
17657,,,614649,[],CHEMBL744288,Compound was evaluated in vivo in urine sample collected over 24 hours for its concentration after 40 mg/kg peroral administration to mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,232374,=,1,0,=,,UR,%,,30.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,UR,%,UO_0000187,,30.0
17658,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,614650,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL626014,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,232374,=,1,1,=,,Cmax,nM,,45269.35,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,15.0
17659,,,614651,[],CHEMBL639404,Compound was evaluated in vivo in blood samples from the orbital sinus for its half life after 40 mg/kg of intramuscular administration in mice.,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,232374,=,1,1,=,,T1/2,hr,,0.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T1/2,min,UO_0000032,,54.0
17660,,,614652,[],CHEMBL622558,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,=,1,1,=,,AUC,ng.hr.mL-1,,21000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug ml-1 hr-1,,,21.0
17661,,,614653,[],CHEMBL744287,Compound was evaluated in vivo in urine sample collected over 24 hours for its concentration after 40 mg/kg intramuscular administration to mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,232374,=,1,0,=,,UR,%,,46.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,UR,%,UO_0000187,,46.0
17662,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,614654,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL626010,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,232374,=,1,1,=,,Cmax,nM,,9053.87,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,Cmax,ug ml-1,UO_0000065,,3.0
17663,,,614655,[],CHEMBL639403,Compound was evaluated in vivo for its half life after 40 mg/kg of peroral administration in dogs.,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,232374,=,1,1,=,,T1/2,hr,,0.05833,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,T1/2,min,UO_0000032,,3.5
17664,,,614656,[],CHEMBL622560,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,232374,=,1,1,=,,AUC,ng.hr.mL-1,,20000.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,AUC,ug ml-1 hr-1,,,20.0
17665,,,614657,[],CHEMBL672478,Compound was evaluated in vivo in urine sample collected over 24 hours for its concentration after 40 mg/kg peroral administration to dogs.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125733,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,232374,=,1,0,=,,UR,%,,17.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,UR,%,UO_0000187,,17.0
17666,,,617250,[],CHEMBL676652,Evaluated for minimum inhibitory concentration against gram-negative bacteria Enterobacter cloacae HA 2646,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.013
17667,,,617251,[],CHEMBL682391,Evaluated for minimum inhibitory concentration against gram-negative bacteria Escherichia coli Vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
17668,,,617252,[],CHEMBL701615,Evaluated for minimum inhibitory concentration against gram-negative bacteria Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.025
17669,,,617253,[],CHEMBL768023,Evaluated for minimum inhibitory concentration against gram-negative bacteria Pseudomonas rettgeri H1771,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL612498,Pseudomonas,Pseudomonas,286.0,,,MIC,ug ml-1,UO_0000274,,0.025
17670,,,617254,[],CHEMBL766010,Evaluated for minimum inhibitory concentration against gram-negative bacteria Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
17671,,,617255,[],CHEMBL809030,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus aureus H228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.6
17672,,,617256,[],CHEMBL809031,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus aureus UC-76,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17673,,,617257,[],CHEMBL811546,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.4
17674,,,617258,[],CHEMBL807300,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.4
17675,,,617259,[],CHEMBL806108,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus pyogenes C203,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17676,,,617260,[],CHEMBL682218,Evaluated for minimum concentration needed to produce linear DNA at an intensity relative to oxolinic acid at 10 mg/mL. by gyrase mediated cleavage of DNA in Escherichia coli 560.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130654,=,1,1,=,,MIC,ug.mL-1,,5.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.2
17677,,,618725,[],CHEMBL672106,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae MA2646",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.013
17678,,,618726,[],CHEMBL674330,"Antibacterial activity was determined against gram negative organism, Escherichia coli vogel",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.013
17679,,,618727,[],CHEMBL702642,"Antibacterial activity was determined against gram negative organism, Klebsiella pneumoniae MGH-2",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
17680,,,618728,[],CHEMBL755847,"Antibacterial activity was determined against gram negative organism, Providencia rettgeri. M1771",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612490,Bacteria,Bacteria,2.0,,,MIC,ug ml-1,UO_0000274,,0.05
17681,,,618729,[],CHEMBL754839,"Antibacterial activity was determined against gram negative organism, Pseudomonas aeruginosa UI-18",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
17682,,,618730,[],CHEMBL798724,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus H228",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.6
17683,,,618731,[],CHEMBL799972,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus UC76",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17684,,,618732,[],CHEMBL799853,"Antibacterial activity was determined against gram positive organism, Streptococcus faecalis MGH-2",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
17685,,,618733,[],CHEMBL799746,"Antibacterial activity was determined against gram positive organism, Streptococcus pneumoniae SV-1",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.8
17686,,,618734,[],CHEMBL801925,"Antibacterial activity was determined against gram positive organism, Streptococcus pyogenes C203",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
17687,,,618735,[],CHEMBL664852,Minimum inhibitory concentration against Escherichia coli DNA-gyrase in supercoiling assay,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,16870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
17688,,,618736,[],CHEMBL674838,The in vivo potency was determined in female charles river CD-1 mice infected with Escherichia coli after peroral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,16870,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.0
17689,,,618737,[],CHEMBL674839,The in vivo potency was determined in female charles river CD-1 mice infected with Escherichia coli after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,16870,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.3
17690,,,618738,[],CHEMBL723256,The in vivo potency was determined in female charles river CD-1 mice infected with Streptococcus pyogenes after peroral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,16870,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,100.0
17691,,,618739,[],CHEMBL723257,The in vivo potency was determined in female charles river CD-1 mice infected with Streptococcus pyogenes after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,16870,=,1,0,=,,PD50,mg kg-1,,19.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,19.0
17692,,,618740,[],CHEMBL723254,The in vivo potency was determined in female charles river CD-1 mice infected with Streptococcus pneumoniae after peroral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,16870,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,100.0
17693,,,618741,[],CHEMBL723255,The in vivo potency was determined in female charles river CD-1 mice infected with Streptococcus pneumoniae after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,16870,=,1,0,=,,PD50,mg kg-1,,228.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,228.0
17694,,,618742,[],CHEMBL682678,MIC ratio measured as the mean MICs of gram-negative bacteria,F,,,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,16870,=,1,0,=,,Ratio,,,0.044,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.044
17695,,,618743,[],CHEMBL682689,MIC ratio measured as the mean MICs of gram-positive bacteria,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,16870,=,1,0,=,,Ratio,,,0.7,CHEMBL612490,Bacteria,Bacteria,2.0,,,Ratio,,,,0.7
17696,,Impermeable,639382,[],CHEMBL741257,BBB penetration classification,A,,,BAO_0002808,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1133022,J Med Chem,2000.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,124834,,1,0,,,Permeability,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Permeability,,,,
17697,,,640659,[],CHEMBL839842,Tested for in vitro antibacterial activity against Gram (+) bacteria,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136788,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,97549,=,1,0,=,,GM-MIC,ug ml-1,,0.99,CHEMBL612545,,Unchecked,,,,GM-MIC,ug ml-1,UO_0000274,,0.99
17698,,,640660,[],CHEMBL686157,In vitro antibacterial activity against Gram (-) bacteria,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136788,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,97549,=,1,0,=,,GM-MIC,ug ml-1,,0.04,CHEMBL612545,,Unchecked,,,,GM-MIC,ug ml-1,UO_0000274,,0.04
17699,,,640661,[],CHEMBL804727,Tested for in vitro antibacterial activity against Streptococcus pneumoniae W1466,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136788,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,97549,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
17700,,,640662,[],CHEMBL715986,Tested for in vitro antibacterial activity against methicillin resistant Staphylococcus aureus W9501,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136788,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,97549,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
17701,,,640663,[],CHEMBL756154,Tested for in vitro antibacterial activity against Pseudomonas aeruginosa W348,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136788,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,97549,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
17702,,,640664,[],CHEMBL672336,Tested for in vitro antibacterial activity against Escherichia coli W9523,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136788,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,97549,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
17703,,,645590,[],CHEMBL807074,Minimum inhibitory concentration against Staphylococcus aureus,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149101,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58615,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
17704,,,645591,[],CHEMBL806953,Minimum inhibitory concentration against Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149101,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58615,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
17705,,,645592,[],CHEMBL871715,Range for minimum inhibitory concentration against Staphylococcus aureus; 0.5->16,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149101,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58615,=,1,0,=,,Range,ug ml-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Range,ug ml-1,UO_0000274,,16.0
17706,,,655137,[],CHEMBL810593,In vitro antibacterial activity against Staphylococcus aureus ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17707,,,655138,[],CHEMBL808638,In vitro antibacterial activity against Staphylococcus aureus CMX 686B,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17708,,,655139,[],CHEMBL882736,In vitro antibacterial activity against Staphylococcus aureus A5177,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17709,,,655140,[],CHEMBL808636,In vitro antibacterial activity against Staphylococcus aureus 45,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
17710,,,655141,[],CHEMBL808916,In vitro antibacterial activity against Staphylococcus epidermidis 3519,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.39
17711,,,655142,[],CHEMBL811310,In vitro antibacterial activity against Streptococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.39
17712,,,655143,[],CHEMBL811080,In vitro antibacterial activity against Streptococcus bovis A5169,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,1.56
17713,,,655144,[],CHEMBL809351,In vitro antibacterial activity against Streptococcus agalactiae CMS 508,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.39
17714,,,655145,[],CHEMBL816714,In vitro antibacterial activity against Streptococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.39
17715,,,655146,[],CHEMBL679693,In vitro antibacterial activity against Escherichia coli Juhl,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
17716,,,655147,[],CHEMBL858152,In vitro antibacterial activity against Enterobacter aerogenes ATCC 13048,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.05
17717,,,655148,[],CHEMBL877921,In vitro antibacterial activity against Klebsiella pneumoniae 8045,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.02
17718,,,655149,[],CHEMBL770053,In vitro antibacterial activity against Pseudomonas aeruginosa 5007,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17719,,,655150,[],CHEMBL770991,In vitro antibacterial activity against Pseudomonas aeruginosa K799/WT,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17720,,,655151,[],CHEMBL644944,In vitro antibacterial activity against Acinetobacter CMX 669,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125111,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29669,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,0.78
17721,,,658150,[],CHEMBL808011,In vitro antimicrobial activity against Staphylococcus aureus giorgio,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17722,,,658151,[],CHEMBL808010,In vitro antimicrobial activity against Staphylococcus aureus 77,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17723,,,658152,[],CHEMBL807237,In vitro antimicrobial activity against Staphylococcus aureus 241,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
17724,,,658153,[],CHEMBL806806,In vitro antimicrobial activity against Staphylococcus epidermis 887E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.13
17725,,,658154,[],CHEMBL806805,In vitro antimicrobial activity against Staphylococcus epidermis 178,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,128.0
17726,,,658155,[],CHEMBL651201,In vitro antimicrobial activity against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.031
17727,,,658156,[],CHEMBL725478,In vitro antimicrobial activity against Micrococcus luteus ATCC 9341,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,4.0
17728,,,658157,[],CHEMBL682197,In vitro antimicrobial activity against Escherichia coli 10536,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17729,,,658158,[],CHEMBL682198,In vitro antimicrobial activity against Escherichia coli 3190Y,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17730,,,658159,[],CHEMBL682199,In vitro antimicrobial activity against Escherichia coli 851E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
17731,,,658160,[],CHEMBL682200,In vitro antimicrobial activity against Escherichia coli TEM5 3739E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.13
17732,,,658161,[],CHEMBL767285,In vitro antimicrobial activity against Pseudomonas aeruginosa 1012E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.13
17733,,,658162,[],CHEMBL636112,In vitro antimicrobial activity against Acinetobacter calcoaceticus 15473,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.25
17734,,,658163,[],CHEMBL660519,In vitro antimicrobial activity against Citrobacter diversus 2046E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC,ug ml-1,UO_0000274,,0.016
17735,,,658164,[],CHEMBL682979,In vitro antimicrobial activity against Enterobacter cloacae p99,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
17736,,,658165,[],CHEMBL703215,In vitro antimicrobial activity against Klebsiella aerogenes 1076E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.13
17737,,,658166,[],CHEMBL801691,In vitro antimicrobial activity against Salmonella Typhimurium 14028,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,129452,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.031
17738,,,658167,[],CHEMBL734520,In vivo efficacy against systemic infection of Staphylococcus aureus giorgio in mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,129452,=,1,1,=,,ED50,mg.kg-1,,7.46,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,7.46
17739,,,658168,[],CHEMBL734519,In vivo efficacy against systemic infection of Pseudomonas aeruginosa 1912E in mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,129452,=,1,1,=,,ED50,mg.kg-1,,3.11,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,3.11
17740,,,658169,[],CHEMBL631242,AUC value after administration of 20 mg/Kg oral dose in rat,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,129452,=,1,1,=,,AUC,ng.hr.mL-1,,2590.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,ug hr ml-1,,,2.59
17741,,,658170,[],CHEMBL625284,Half-life after administration of 20 mg/Kg oral dose in rat,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,129452,=,1,1,=,,T1/2,hr,,1.87,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T1/2,hr,UO_0000032,,1.87
17742,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,658171,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL627600,Cmax value after administration of 20 mg/Kg oral dose in rat,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,129452,=,1,1,=,,Cmax,nM,,2716.16,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,0.9
17743,,,658172,[],CHEMBL621128,Tmax value after administration of 20 mg/Kg oral dose in rat,A,,,BAO_0003037,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,129452,=,1,1,=,,Tmax,hr,,0.11,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T max,hr,UO_0000032,,0.11
17744,,,658173,[],CHEMBL622034,Bioavailability in rat (dose 20 mg/kg p.o.),A,,,BAO_0003042,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,129452,=,1,1,=,,F,%,,44.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,F,%,UO_0000187,,44.5
17745,,,658174,[],CHEMBL624257,AUC value after administration of 4 mg/Kg oral dose in dog,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,129452,=,1,1,=,,AUC,ng.hr.mL-1,,4540.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,AUC,ug hr ml-1,,,4.54
17746,,,658175,[],CHEMBL621553,Half-life after administration of 4 mg/Kg oral dose in dog,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,129452,=,1,1,=,,T1/2,hr,,1.7,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,T1/2,hr,UO_0000032,,1.7
17747,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,658176,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL621661,Cmax value after administration of 4 mg/Kg oral dose in dog,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,129452,=,1,1,=,,Cmax,nM,,2746.34,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,Cmax,ug ml-1,UO_0000065,,0.91
17748,,,658177,[],CHEMBL872527,Tmax value after administration of 4 mg/Kg oral dose in dog,A,,,BAO_0003037,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,129452,=,1,1,=,,Tmax,hr,,1.12,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,T max,hr,UO_0000032,,1.12
17749,,,658178,[],CHEMBL624437,Bioavailability in dog (dose 4 mg/kg p.o.),A,,,BAO_0003042,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130731,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,129452,=,1,1,=,,F,%,,71.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,F,%,UO_0000187,,71.0
17750,,,662466,[],CHEMBL799749,In vitro antimicrobial activity against strain Streptococcus pneumoniae 9585,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
17751,,,662467,[],CHEMBL674334,In vitro antimicrobial activity against strain Enterococcus faecalis 9809,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17752,,,662468,[],CHEMBL797995,In vitro antimicrobial activity against strain Staphylococcus aureus 9537,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
17753,,,662469,[],CHEMBL671292,In vitro antimicrobial activity against strain Escherichia coli 15119,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17754,,,662470,[],CHEMBL706027,In vitro antimicrobial activity against strain Klebsiella pneumoniae 9664,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
17755,,,662471,[],CHEMBL672108,In vitro antimicrobial activity against strain Enterobacter cloacae 9656,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
17756,,,662472,[],CHEMBL754953,In vitro antimicrobial activity against strain Proteus mirabilis 9900,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.008
17757,,,662473,[],CHEMBL706439,In vitro antimicrobial activity against strain Morganella morganii 15153,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.08
17758,,,662474,[],CHEMBL755254,In vitro antimicrobial activity against strain Pseudomonas aeruginosa 9843,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126020,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,105366,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17759,,,675391,[],CHEMBL673972,Biological activity against Escherichia coli N1HJ JC-2 relative to Norfloxacin.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125906,J Med Chem,1991.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,44190,=,1,0,=,,pMIC,M l-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,pMIC,M l-1,,,4.0
17760,,,741008,[],CHEMBL809921,In vitro Minimum inhibitory concentration against Staphylococcus aureus ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17761,,,741009,[],CHEMBL882255,In vitro Minimum inhibitory concentration against Staphylococcus aureus CMX 686B,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17762,,,741010,[],CHEMBL809920,In vitro Minimum inhibitory concentration against Staphylococcus aureus A5177,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
17763,,,741011,[],CHEMBL809919,In vitro Minimum inhibitory concentration against Staphylococcus aureus 45,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
17764,,,741012,[],CHEMBL808913,In vitro Minimum inhibitory concentration against Staphylococcus epidermidis 3519,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.78
17765,,,741013,[],CHEMBL811308,In vitro Minimum inhibitory concentration against Streptococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.39
17766,,,741014,[],CHEMBL810219,In vitro Minimum inhibitory concentration against Streptococcus bovis A5169,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,1.56
17767,,,741015,[],CHEMBL809349,In vitro Minimum inhibitory concentration against Streptococcus agalactiae CMX 508,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.78
17768,,,741016,[],CHEMBL816705,In vitro Minimum inhibitory concentration against Streptococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.78
17769,,,741017,[],CHEMBL677717,In vitro Minimum inhibitory concentration against Escherichia coli Juhl,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
17770,,,741018,[],CHEMBL701618,In vitro Minimum inhibitory concentration against Klebsiella pneumoniae 8045,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.02
17771,,,741019,[],CHEMBL766022,In vitro Minimum inhibitory concentration against Pseudomonas aeruginosa 5007,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
17772,,,741020,[],CHEMBL766023,In vitro Minimum inhibitory concentration against Pseudomonas aeruginosa K799/WT,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17773,,,741021,[],CHEMBL644943,In vitro Minimum inhibitory concentration against Acinetobacter CMX 669,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,0.39
17774,,,741022,[],CHEMBL813012,"In vivo efficacy against Staphylococcus aureus 10649, in mouse protection tests when administered subcutaneously (sc)",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,67554,=,1,1,=,,ED50,mg.kg-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,1.6
17775,,,741023,[],CHEMBL813011,"In vivo efficacy against Staphylococcus aureus 10649, in mouse protection tests when administered perorally (po)",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,67554,=,1,1,=,,ED50,mg.kg-1,,15.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,15.5
17776,,,741024,[],CHEMBL736796,"In vivo efficacy against Escherichia coli Juhl, in mouse protection tests when administered subcutaneously (sc)",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,67554,=,1,1,=,,ED50,mg.kg-1,,0.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,0.2
17777,,,741025,[],CHEMBL736795,"In vivo efficacy against Escherichia coli Juhl, in mouse protection tests when administered perorally (po)",F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,67554,=,1,1,=,,ED50,mg.kg-1,,1.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,1.9
17778,,,741026,[],CHEMBL679270,Supercoiling inhibition assay using purified DNA gyrase isolated from Escherichia coli H560,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,IC50,ug.mL-1,,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,I50,ug ml-1,UO_0000274,,0.9
17779,,,741027,[],CHEMBL876630,Compound was evaluated for the solubility in Ringer's buffer solution,A,,,BAO_0002135,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,1,=,,Solubility,ug.mL-1,,92.0,CHEMBL612558,,ADMET,,,,Solubility,mg ml-1,UO_0000274,,0.092
17780,,,741028,[],CHEMBL640142,Partition coefficient (logP),P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,67554,=,1,1,=,,LogP,,,-1.16,CHEMBL2362975,,No relevant target,,,,logP,,,,-1.16
17781,,,741029,[],CHEMBL733925,Blood level was evaluated by a disk agar diffusion assay at 0.5 hr when administered at a peroral dose of 25 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,0,=,,Blood level,ug ml-1,,1.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Blood level,ug ml-1,UO_0000274,,1.3
17782,,,741030,[],CHEMBL733929,Blood level was evaluated by a disk agar diffusion assay at 1.0 hr when administered at a peroral dose of 25 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,0,=,,Blood level,ug ml-1,,0.8,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Blood level,ug ml-1,UO_0000274,,0.8
17783,,,741031,[],CHEMBL733932,Blood level was evaluated by a disk agar diffusion assay at 2.0 hr when administered at a peroral dose of 25 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,0,=,,Blood level,ug ml-1,,0.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Blood level,ug ml-1,UO_0000274,,0.3
17784,,,741032,[],CHEMBL731399,Blood level was evaluated by a disk agar diffusion assay at 3.0 hh when administered at a peroral dose of 25 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,0,=,,Blood level,ug ml-1,,0.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Blood level,ug ml-1,UO_0000274,,0.1
17785,,,741033,[],CHEMBL731994,Blood level was evaluated by a disk agar diffusion assay at 6.0 hr when administered at a peroral dose of 25 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,0,=,,Blood level,ug ml-1,,0.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Blood level,ug ml-1,UO_0000274,,0.0
17786,,,741034,[],CHEMBL731395,Blood level was evaluated by a disk agar diffusion assay at 24.0 hr when administered at a peroral dose of 25 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124182,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,67554,=,1,0,=,,Blood level,ug ml-1,,0.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Blood level,ug ml-1,UO_0000274,,0.0
17787,,,746404,[],CHEMBL808758,Minimum inhibitory concentration tested against Staphylococcus aureus 1199 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81499,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
17788,,,746405,[],CHEMBL808759,Minimum inhibitory concentration tested against Staphylococcus aureus 1199-3 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81499,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
17789,,,746406,[],CHEMBL808760,Minimum inhibitory concentration tested against Staphylococcus aureus 1199B strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81499,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
17790,,,746407,[],CHEMBL808761,Minimum inhibitory concentration tested against methicillin resistant Staphylococcus aureus 494 strain (MRSA 494),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81499,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17791,,,746408,[],CHEMBL808830,Minimum inhibitory concentration tested against vancomycin-insensitive SA (GISA 992 strain),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81499,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
17792,,,783156,[],CHEMBL673969,Antibacterial activity against Escherichia coli ATCC 8739(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Log2 MIC,,,,12.0
17793,,,783157,[],CHEMBL673971,Antibacterial activity against Escherichia coli ISF 432(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,13.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Log2 MIC,,,,13.0
17794,,,783158,[],CHEMBL675786,Antibacterial activity against Enterobacter cloacae OMNFI 174 (Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,13.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Log2 MIC,,,,13.0
17795,,,783159,[],CHEMBL636120,Antibacterial activity against Acinetobacter calcoaceticus OSMPV 113 (Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,Log2 MIC,,,,11.0
17796,,,783160,[],CHEMBL767634,Antibacterial activity against Providencia stuartii CNUR 5(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,Log2 MIC,,,,11.0
17797,,,783161,[],CHEMBL703158,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 (Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,12.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Log2 MIC,,,,12.0
17798,,,783162,[],CHEMBL804823,Antibacterial activity against Shigella enteritidis (Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,12.0,CHEMBL614594,Shigella,Shigella,620.0,,,Log2 MIC,,,,12.0
17799,,,783163,[],CHEMBL770331,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Log2 MIC,,,,11.0
17800,,,783164,[],CHEMBL808785,Antibacterial activity against Staphylococcus aureus MPR 5 (Gram positive) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Log2 MIC,,,,10.0
17801,,,783165,[],CHEMBL813139,Antibacterial activity against Staphylococcus aureus ATCC 6538 (Gram positive) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Log2 MIC,,,,10.0
17802,,,783166,[],CHEMBL805493,Antibacterial activity against Staphylococcus epidermidis HCF Berset C (Gram positive) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,10.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Log2 MIC,,,,10.0
17803,,,783167,[],CHEMBL805496,"Antibacterial activity against Staphylococcus epidermidis CPHL A2 (Gram positive) strain, activity is expressed as log2MIC.",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Log2 MIC,,,,11.0
17804,,,783168,[],CHEMBL812157,Antibacterial activity against Streptococcus faecalis LEP Br (Gram positive) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Log2 MIC,,,,8.0
17805,,,783169,[],CHEMBL673969,Antibacterial activity against Escherichia coli ATCC 8739(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,13.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Log2 MIC,,,,13.0
17806,,,783170,[],CHEMBL673971,Antibacterial activity against Escherichia coli ISF 432(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,13.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Log2 MIC,,,,13.0
17807,,,783171,[],CHEMBL675786,Antibacterial activity against Enterobacter cloacae OMNFI 174 (Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,13.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Log2 MIC,,,,13.0
17808,,,783172,[],CHEMBL636121,The compound was tested for in vitro antibacterial activity against Acinetobacter calcoaceticus OSMPV 113(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,10.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,Log2 MIC,,,,10.0
17809,,,783173,[],CHEMBL767634,Antibacterial activity against Providencia stuartii CNUR 5(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,Log2 MIC,,,,11.0
17810,,,783174,[],CHEMBL703161,The compound was tested for in vitro antibacterial activity against Klebsiella pneumoniae ATCC 10031(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,13.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Log2 MIC,,,,13.0
17811,,,783175,[],CHEMBL804823,Antibacterial activity against Shigella enteritidis (Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL614594,Shigella,Shigella,620.0,,,Log2 MIC,,,,11.0
17812,,,783176,[],CHEMBL770491,The compound was tested for in vitro antibacterial activity against Pseudomonas aeruginosa ATCC 9027(Gram negative) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Log2 MIC,,,,11.0
17813,,,783177,[],CHEMBL808785,Antibacterial activity against Staphylococcus aureus MPR 5 (Gram positive) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Log2 MIC,,,,11.0
17814,,,783178,[],CHEMBL813139,Antibacterial activity against Staphylococcus aureus ATCC 6538 (Gram positive) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Log2 MIC,,,,11.0
17815,,,783179,[],CHEMBL805493,Antibacterial activity against Staphylococcus epidermidis HCF Berset C (Gram positive) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Log2 MIC,,,,11.0
17816,,,783180,[],CHEMBL805494,The compound was tested in vitro for antibacterial activity against Staphylococcus epidermidis CPHL A2 (Gram positive) strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,11.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Log2 MIC,,,,11.0
17817,,,783181,[],CHEMBL812157,Antibacterial activity against Streptococcus faecalis LEP Br (Gram positive) strain.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130043,J Med Chem,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,77285,=,1,0,=,,Log2 MIC,,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Log2 MIC,,,,8.0
17818,,,803568,[],CHEMBL809492,In vitro antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
17819,,,803569,[],CHEMBL810413,In vitro antibacterial activity against Staphylococcus aureus MPR 5,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17820,,,803570,[],CHEMBL810412,In vitro antibacterial activity against Staphylococcus aureus M-R POMM 6214,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
17821,,,803571,[],CHEMBL810594,In vitro antibacterial activity against Staphylococcus aureus CPX-R OBT 687,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
17822,,,803572,[],CHEMBL816719,In vitro antibacterial activity against Streptococcus pyogenes OMNFI BI,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
17823,,,803573,[],CHEMBL813861,In vitro antibacterial activity against Streptococcus pneumoniae I 0.43,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
17824,,,803574,[],CHEMBL674852,In vitro antibacterial activity against Enterococcus faecalis LEP Br,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
17825,,,803575,[],CHEMBL674853,In vitro antibacterial activity against Enterococcus faecalis UCMC 39690,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17826,,,803576,[],CHEMBL679689,In vitro antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,<,1,1,<,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
17827,,,803577,[],CHEMBL677296,In vitro antibacterial activity against Escherichia coli 120,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,<,1,1,<,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
17828,,,803578,[],CHEMBL878526,In vitro antibacterial activity against Escherichia coliCPX-R OBT 431,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
17829,,,803579,[],CHEMBL676661,In vitro antibacterial activity against Enterobacter cloacae OMNFI 174,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,<,1,1,<,,MIC,ug.mL-1,,0.016,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.016
17830,,,803580,[],CHEMBL763271,In vitro antibacterial activity against Proteus mirabilis OBT 505,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.06
17831,,,803581,[],CHEMBL767769,In vitro antibacterial activity against Proteus vulgaris CNUR 6,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.5
17832,,,803582,[],CHEMBL701625,In vitro antibacterial activity against Klebsiella pneumoniae ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,<,1,1,<,,MIC,ug.mL-1,,0.016,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.016
17833,,,803583,[],CHEMBL878792,In vitro antibacterial activity against Pseudomonas aeruginosa ATC1C 9027,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
17834,,,803584,[],CHEMBL766574,In vitro antibacterial activity against Pseudomonas aeruginosa OBT 307,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
17835,,,803585,[],CHEMBL696272,In vitro antibacterial activity against Haemophilus influenzae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,<,1,1,<,,MIC,ug.mL-1,,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.016
17836,,,803586,[],CHEMBL686745,Inhibitory effect against Escherichia coli Gyrase in Supercoiling assay,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,IC50,ug.mL-1,,0.68,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,0.68
17837,,,803587,[],CHEMBL848482,Mean MIC against gram positive,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.917,CHEMBL612545,,Unchecked,,,,Mean MIC,ug ml-1,UO_0000274,,0.917
17838,,,803588,[],CHEMBL848996,Mean MIC against gram negative,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,284463,=,1,1,=,,MIC,ug.mL-1,,0.083,CHEMBL612545,,Unchecked,,,,Mean MIC,ug ml-1,UO_0000274,,0.083
17839,,,803589,[],CHEMBL625498,Calculated partition coefficient (clogP),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129595,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,284463,=,1,1,=,,CLogP,,,-0.805,CHEMBL2362975,,No relevant target,,,,clogP,,,,-0.805
17840,,,812416,[],CHEMBL651228,The compound was tested for minimal inhibitory concentration against Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
17841,,,812417,[],CHEMBL727008,The compound was tested for minimal inhibitory concentration against Micrococcus luteus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
17842,,,812418,[],CHEMBL810473,The compound was tested for minimal inhibitory concentration against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
17843,,,812419,[],CHEMBL679095,The compound was tested for minimal inhibitory concentration against Enterobacter sp.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,MIC,ug ml-1,UO_0000274,,2.0
17844,,,812420,[],CHEMBL673722,The compound was tested for minimal inhibitory concentration against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
17845,,,812421,[],CHEMBL878675,The compound was tested for minimal inhibitory concentration against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
17846,,,812422,[],CHEMBL753616,The compound was tested for minimal inhibitory concentration against Neisseria gonorrhoeae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.25
17847,,,812423,[],CHEMBL883406,The compound was tested for minimal inhibitory concentration against Penicillinase producing Neisseria gonorrhoeae (PPNG),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.25
17848,,,812424,[],CHEMBL689959,The compound was tested for minimal inhibitory concentration against Haemophilus ducreyi,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614604,[Haemophilus] ducreyi,[Haemophilus] ducreyi,730.0,,,MIC,ug ml-1,UO_0000274,,1.0
17849,,,812425,[],CHEMBL813054,The compound was tested for minimal inhibitory concentration against Resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
17850,,,812426,[],CHEMBL771071,The compound was tested for minimal inhibitory concentration against Resistant Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1134904,Bioorg Med Chem Lett,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144542,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
17851,,,906002,[],CHEMBL682926,Minimum inhibitory concentration against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136372,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,69975,=,1,1,=,,MIC,nM,,80.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.08
17852,,,906003,[],CHEMBL814219,Minimum inhibitory concentration (MIC) against Staphylococcus aureus ATCC 13709,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136372,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,69975,=,1,1,=,,MIC,nM,,600.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.6
17853,,,958944,[],CHEMBL677358,Minimum inhibitory concentration against Enterobacter cloacae MA 2646,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
17854,,,958945,[],CHEMBL679317,Minimum inhibitory concentration against Escherichia coli Vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
17855,,,958946,[],CHEMBL700980,Minimum inhibitory concentration against Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
17856,,,958947,[],CHEMBL767757,Minimum inhibitory concentration against M1771 strain of Providencia rettgeri,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.1
17857,,,958948,[],CHEMBL762950,Minimum inhibitory concentration against U1-18 cell line from Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
17858,,,958949,[],CHEMBL805931,Minimum inhibitory concentration against Staphylococcus aureus H 228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
17859,,,958950,[],CHEMBL805932,Minimum inhibitory concentration against Staphylococcus aureus UC-76,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17860,,,958951,[],CHEMBL814019,Minimum inhibitory concentration against Streptococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
17861,,,958952,[],CHEMBL882128,Minimum inhibitory concentration tested against Streptococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
17862,,,958953,[],CHEMBL809196,Minimum inhibitory concentration against Streptococcus pyogenes C203,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
17863,,,958954,[],CHEMBL742219,In vivo antibacterial activity against Escherichia coli after following oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,320542,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.0
17864,,,958955,[],CHEMBL742220,In vivo antibacterial activity against Escherichia coli after following subcutaneous administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,320542,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.3
17865,,,958956,[],CHEMBL742221,In vivo antibacterial activity against Streptococcus pyogenes after following oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,320542,=,1,0,=,,PD50,mg kg-1,,180.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,180.0
17866,,,958957,[],CHEMBL742222,In vivo antibacterial activity against Streptococcus pyogenes after following subcutaneous administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,320542,=,1,0,=,,PD50,mg kg-1,,19.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,19.0
17867,,,958958,[],CHEMBL738872,The no effect dose (NED) for phototoxicity in mouse,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,320542,>,1,0,>,,NED,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,NED,mg kg-1,UO_0000308,,100.0
17868,,,958959,[],CHEMBL812295,Clonogenic cytotoxicity against Hamster V-79 cells,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1127665,J Med Chem,1994.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320542,>,1,1,>,,IC50,ug.mL-1,,200.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,,IC50,ug ml-1,UO_0000274,,200.0
17869,,,973112,[],CHEMBL807153,Antibacterial activity was determined against Staphylococcus aureus FDA 209-P strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
17870,,,973113,[],CHEMBL804403,Antibacterial activity was determined against Staphylococcus epidermis 56500 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.2
17871,,,973114,[],CHEMBL809336,Antibacterial activity was determined against Streptococcus pneumoniae J-24 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.39
17872,,,973115,[],CHEMBL808948,Antibacterial activity was determined against Streptococcus pyogenes G-36 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,1.56
17873,,,973116,[],CHEMBL812014,Antibacterial activity was determined against Streptococcus mitis IID685 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.78
17874,,,973117,[],CHEMBL679636,Antibacterial activity was determined against Enterococcus faecalis ATCC 19433 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.78
17875,,,973118,[],CHEMBL674794,Antibacterial activity was determined against Escherichia coli NIHJ strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,<=,1,1,<=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
17876,,,973119,[],CHEMBL700140,Antibacterial activity was determined against Klebsiella pneumoniae type II strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.025
17877,,,973120,[],CHEMBL772626,Antibacterial activity was determined against Pseudomonas aeruginosa PAO1 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1761,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.05
17878,,,980006,[],CHEMBL807836,In vitro minimum inhibitory concentration was determined for antibacterial activity against Staphylococcus aureus 6538p strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
17879,,,980007,[],CHEMBL807838,In vitro minimum inhibitory concentration was determined for antibacterial activity against Staphylococcus aureus giorgio strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17880,,,980008,[],CHEMBL807837,In vitro minimum inhibitory concentration was determined for antibacterial activity against Staphylococcus aureus 77 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17881,,,980009,[],CHEMBL810363,In vitro minimum inhibitory concentration was determined for antibacterial activity against Staphylococcus aureus 241 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
17882,,,980010,[],CHEMBL806977,In vitro minimum inhibitory concentration was determined for antibacterial activity against Staphylococcus epidermis 887E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.13
17883,,,980011,[],CHEMBL806976,In vitro minimum inhibitory concentration was determined for antibacterial activity against Staphylococcus epidermis 178 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,128.0
17884,,,980012,[],CHEMBL814008,In vitro minimum inhibitory concentration was determined for antibacterial activity against Staphylococcus faecalis 29212 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17885,,,980013,[],CHEMBL650968,In vitro minimum inhibitory concentration was determined for antibacterial activity against Bacillus subtilis ATCC 6633 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.031
17886,,,980014,[],CHEMBL729956,In vitro minimum inhibitory concentration was determined for antibacterial activity against Micrococcus luteus ATCC 9341 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,4.0
17887,,,980015,[],CHEMBL679000,In vitro minimum inhibitory concentration was determined for antibacterial activity against Escherichia coli 10536 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17888,,,980016,[],CHEMBL679001,In vitro minimum inhibitory concentration was determined for antibacterial activity against Escherichia coli 3190Y strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17889,,,980017,[],CHEMBL679002,In vitro minimum inhibitory concentration was determined for antibacterial activity against Escherichia coli 851E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
17890,,,980018,[],CHEMBL679003,In vitro minimum inhibitory concentration was determined for antibacterial activity against Escherichia coli TEM5 3739E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.13
17891,,,980019,[],CHEMBL679004,In vitro minimum inhibitory concentration was determined for antibacterial activity against Escherichia coli TEM9 2639E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
17892,,,980020,[],CHEMBL769414,In vitro minimum inhibitory concentration was determined for antibacterial activity against Pseudomonas aeruginosa 1012E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.13
17893,,,980021,[],CHEMBL769415,In vitro minimum inhibitory concentration was determined for antibacterial activity against Pseudomonas aeruginosa 10145 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17894,,,980022,[],CHEMBL636114,In vitro minimum inhibitory concentration was determined for antibacterial activity against Acinetobacter calcoaceticus 15473 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.25
17895,,,980023,[],CHEMBL657686,In vitro minimum inhibitory concentration was determined for antibacterial activity against Citrobacter diversus 2046E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC,ug ml-1,UO_0000274,,0.016
17896,,,980024,[],CHEMBL679447,In vitro minimum inhibitory concentration was determined for antibacterial activity against Enterobacter cloacae 1194E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.031
17897,,,980025,[],CHEMBL679448,In vitro minimum inhibitory concentration was determined for antibacterial activity against Enterobacter cloacae p99 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
17898,,,980026,[],CHEMBL703216,In vitro minimum inhibitory concentration was determined for antibacterial activity against Klebsiella aerogenes 1076E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.13
17899,,,980027,[],CHEMBL703217,In vitro minimum inhibitory concentration was determined for antibacterial activity against Klebsiella aerogenes 1082E strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.008
17900,,,980028,[],CHEMBL801693,In vitro minimum inhibitory concentration was determined for antibacterial activity against Salmonella Typhimurium 14028 strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1130486,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,93726,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.031
17901,,Not Active,1009495,[],CHEMBL682685,In vitro activity in agar dilution-streak assay against Gram-positive bacteria at 100 ug/ml; IA means Inactive,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129916,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,11243,,1,0,,,Activity,,,,CHEMBL612490,Bacteria,Bacteria,2.0,,,Activity,,,,
17902,,Not Active,1009496,[],CHEMBL682680,In vitro activity in agar dilution-streak assay against Gram-negative bacteria at 100 ug/ml; IA means Inactive,F,,,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129916,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,11243,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
17903,,,1011997,[],CHEMBL858071,In vitro antibacterial activity expressed as MIC against Streptococcus pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
17904,,,1011998,[],CHEMBL678223,In vitro antibacterial activity expressed as MIC against Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17905,,,1011999,[],CHEMBL858066,In vitro antibacterial activity expressed as MIC against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
17906,,,1012000,[],CHEMBL812557,In vitro antibacterial activity expressed as MIC against Staphylococcus epidermidis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
17907,,,1012001,[],CHEMBL681235,In vitro antibacterial activity expressed as MIC against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17908,,,1012002,[],CHEMBL878634,In vitro antibacterial activity expressed as MIC against Klebsiella oxytoca,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.06
17909,,,1012003,[],CHEMBL679067,In vitro antibacterial activity expressed as MIC against Enterobacter aerogenes,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.03
17910,,,1012004,[],CHEMBL763274,In vitro antibacterial activity expressed as MIC against Proteus mirabilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.008
17911,,,1012005,[],CHEMBL732156,In vitro antibacterial activity expressed as MIC against Morganella morganii II,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.08
17912,,,1012006,[],CHEMBL767513,In vitro antibacterial activity expressed as MIC against Providencia stuartii II,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,MIC,ug ml-1,UO_0000274,,0.03
17913,,,1012007,[],CHEMBL805857,In vitro antibacterial activity expressed as MIC against Serratia marcescens,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.03
17914,,,1012008,[],CHEMBL766582,In vitro antibacterial activity expressed as MIC against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17915,,,1012009,[],CHEMBL696277,In vitro antibacterial activity expressed as MIC against Haemophilus influenzae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
17916,,,1012010,[],CHEMBL772074,In vitro antibacterial activity expressed as MIC against Clostridium perfringens,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.06
17917,,,1012011,[],CHEMBL772080,In vitro antibacterial activity expressed as MIC against Providencia rettgeri,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.5
17918,,,1012012,[],CHEMBL657330,In vitro inhibitory concentration which show total effect against Escherichia coli HR DNA gyrase,B,,,BAO_0000179,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,0,=,,IC0,ug ml-1,,0.12,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC0,ug ml-1,UO_0000274,,0.12
17919,,,1012013,[],CHEMBL657332,In vitro inhibitory concentration which show total effect against Escherichia coli HR DNA gyrase,B,,,BAO_0000179,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,0,=,,IC100,ug ml-1,,10.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC100,ug ml-1,UO_0000274,,10.0
17920,,,1012014,[],CHEMBL857618,In vitro antibacterial activity expressed as MIC against Escherichia coli HR DNA gyrase,B,,,BAO_0002146,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310180,=,1,1,=,,MIC,ug.mL-1,,0.009,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,MIC,ug ml-1,UO_0000274,,0.009
17921,,,1016583,[],CHEMBL810960,Antibacterial activity against Streptococcus pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
17922,,,1016584,[],CHEMBL676019,In vitro for antibacterial activity against Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17923,,,1016585,[],CHEMBL811148,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
17924,,,1016586,[],CHEMBL676855,In vitro for antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17925,,,1016587,[],CHEMBL704960,In vitro for antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
17926,,,1016588,[],CHEMBL679408,In vitro for antibacterial activity against Enterobacter cloacae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
17927,,,1016589,[],CHEMBL765700,In vitro for antibacterial activity against Proteus mirabilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.008
17928,,,1016590,[],CHEMBL732148,In vitro for antibacterial activity against Morganella morganii,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.008
17929,,,1016591,[],CHEMBL810634,In vitro for antibacterial activity against Serratia marcescens,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.03
17930,,,1016592,[],CHEMBL764758,In vitro for antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17931,,,1016593,[],CHEMBL649471,In vitro for antibacterial activity against Bacillus fragilis.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,291880,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,4.0
17932,,,1016594,[],CHEMBL808692,Compound was tested for acute toxicity against Staphylococcus aureus A 15090 after oral administration of drug in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,291880,=,1,0,=,,PD50,mg kg-1,,8.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,PD50,mg kg-1,UO_0000308,,8.0
17933,,,1016595,[],CHEMBL811290,Compound was tested for acute toxicity against Streptococcus pneumoniae A 9585 after oral administration of drug in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,291880,>,1,0,>,,PD50,mg kg-1,,50.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,50.0
17934,,,1016596,[],CHEMBL673559,Compound was tested for acute toxicity against Escherichia coli A 15119 after oral administration of drug in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,291880,=,1,0,=,,PD50,mg kg-1,,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.2
17935,,,1016597,[],CHEMBL764916,Compound was tested for acute toxicity against Pseudomonas aeruginosa A 9843 after oral administration of drug in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,291880,=,1,0,=,,PD50,mg kg-1,,2.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,2.6
17936,,,1016598,[],CHEMBL741651,Lethal dose was determined in OF1-strain female Swiss mice after intra venous administration of the drug,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,291880,=,1,1,=,,LD50,mg.kg-1,,273.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,273.0
17937,,,1016599,[],CHEMBL741652,Lethal dose was determined in OF1-strain female Swiss mice after oral administration of the drug,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126152,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,291880,=,1,1,=,,LD50,mg.kg-1,,5000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,5000.0
17938,,,1020559,[],CHEMBL807115,In vitro antibacterial activity against Streptococcus pneumoniae A9585.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
17939,,,1020560,[],CHEMBL675156,In vitro antibacterial activity against Enterococcus faecalis A9809,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
17940,,,1020561,[],CHEMBL801161,In vitro antibacterial activity against Staphylococcus aureus A9537,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
17941,,,1020562,[],CHEMBL670831,In vitro antibacterial activity against Escherichia coli A15119,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
17942,,,1020563,[],CHEMBL703044,In vitro antibacterial activity against Klebsiella pneumoniae A9664,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
17943,,,1020564,[],CHEMBL674192,In vitro antibacterial activity against Enterobacter cloacae A9656,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
17944,,,1020565,[],CHEMBL754559,In vitro antibacterial activity against Proteus mirabilis A9900,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.008
17945,,,1020566,[],CHEMBL706611,In vitro antibacterial activity against Morganella morganii A15153,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.008
17946,,,1020567,[],CHEMBL802013,In vitro antibacterial activity against Serratia marcescens A20019,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.03
17947,,,1020568,[],CHEMBL753153,In vitro antibacterial activity against Pseudomonas aeruginosa A9843,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
17948,,,1020569,[],CHEMBL647681,"In vitro antibacterial activity against Bacteroides fragilis A-22,862",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,1.0
17949,,,1020570,[],CHEMBL820573,In vivo efficacy on systemic infections caused by Staphylococcus aureus A15090 in mice after intramuscular administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,0,=,,PD50,mg kg-1,,3.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,3.9
17950,,,1020571,[],CHEMBL820574,In vivo efficacy on systemic infections caused by Staphylococcus aureus A15090 in mice after peroral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,0,=,,PD50,mg kg-1,,12.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,12.5
17951,,,1020572,[],CHEMBL880766,In vivo efficacy on systemic infections caused by Pseudomonas aeruginosa A9843 in mice after intramuscular administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,0,=,,PD50,mg kg-1,,1.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.3
17952,,,1020573,[],CHEMBL820572,In vivo efficacy on systemic infections caused by Pseudomonas aeruginosa A9843 in mice after peroral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,0,=,,PD50,mg kg-1,,2.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,2.6
17953,,,1020574,[],CHEMBL820569,In vivo efficacy on systemic infections caused by Escherichia coli A15119 in mice after intramuscular administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,0,=,,PD50,mg kg-1,,0.05,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.05
17954,,,1020575,[],CHEMBL820570,In vivo efficacy on systemic infections caused by Escherichia coli A15119 in mice after peroral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,0,=,,PD50,mg kg-1,,1.4,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.4
17955,,,1020576,[],CHEMBL820575,In vivo efficacy on systemic infections caused by Streptococcus pneumoniae A9585 in mice after intramuscular administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,0,=,,PD50,mg kg-1,,28.7,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,28.7
17956,,,1020577,[],CHEMBL821213,In vivo efficacy on systemic infections caused by Streptococcus pneumoniae A9585 in mice after peroral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,>,1,0,>,,PD50,mg kg-1,,50.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,50.0
17957,,,1020578,[],CHEMBL639246,Acute toxicity after intravenous administration to mice,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,1,=,,LD50,mg.kg-1,,273.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,273.0
17958,,,1020579,[],CHEMBL639247,Acute toxicity after peroral administration to mice,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,1,=,,LD50,mg.kg-1,,5000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,5000.0
17959,,,1020580,[],CHEMBL632604,"Solubility (water, 22C, pH 7.2)",P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,183226,=,1,1,=,,Solubility,ug.mL-1,,70.0,CHEMBL2362975,,No relevant target,,,,S,mg ml-1,UO_0000274,,0.07
17960,,,1020581,[],CHEMBL877661,Partition coefficient (logD),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,1,=,,LogD,,,0.7,CHEMBL2362975,,No relevant target,,,,logD,,,,0.7
17961,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1020582,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL623791,Peak concentration in blood after peroral administration to mice,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,183226,=,1,1,=,,Cmax,nM,,18107.74,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,6.0
17962,,,1020583,[],CHEMBL633677,Plasma half-life after peroral administration to mice,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,183226,=,1,1,=,,T1/2,hr,,0.9333,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T1/2,min,UO_0000032,,56.0
17963,,,1020584,[],CHEMBL626166,Area under curve measured as conc vs time after peroral administration to mice.,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,1,=,,AUC,ng.hr.mL-1,,8000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug hr-1 ml-1,,,8.0
17964,,,1020585,[],CHEMBL638293,Percent urinary recovery in 24 hr after peroral administration to mice,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,183226,=,1,0,=,,UR,%,,30.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,UR,%,UO_0000187,,30.0
17965,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1020586,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL623790,Peak concentration in blood after intravenous administration to mice,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,183226,=,1,1,=,,Cmax,nM,,66395.05,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,22.0
17966,,,1020587,[],CHEMBL633676,Plasma half-life after intravenous administration to mice,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,183226,=,1,1,=,,T1/2,hr,,1.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T1/2,min,UO_0000032,,72.0
17967,,,1020588,[],CHEMBL626165,Area under curve measured as conc vs time after intravenous administration to mice.,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,183226,=,1,1,=,,AUC,ng.hr.mL-1,,19000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug hr-1 ml-1,,,19.0
17968,,,1020589,[],CHEMBL746827,percent urinary recovery in 24 hr after intravenous administration to mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125506,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,183226,=,1,0,=,,UR,%,,25.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,UR,%,UO_0000187,,25.0
17969,,,1024081,[],CHEMBL630253,Percent of the drug absorbed after administration to humans was determined,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132208,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,81392,=,1,0,=,,Absorption,%,,69.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Absorption,%,UO_0000187,,69.0
17970,,,1024350,[],CHEMBL634764,Compound was evaluated for aqueous solubility at pH 7.2,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307226,=,1,1,=,,Solubility,ug.mL-1,,90.0,CHEMBL2362975,,No relevant target,,,,Solubility,mg ml-1,UO_0000274,,0.09
17971,,,1031814,[],CHEMBL809486,In vitro antibacterial activity against Staphylococcus aureus 209P JC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
17972,,,1031815,[],CHEMBL809487,In vitro antibacterial activity against Staphylococcus aureus 50774,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
17973,,,1031816,[],CHEMBL813401,In vitro antibacterial activity against Streptococcus epidermis 8,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.1
17974,,,1031817,[],CHEMBL816717,In vitro antibacterial activity against Streptococcus pyogenes A65,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.2
17975,,,1031818,[],CHEMBL813995,In vitro antibacterial activity against Streptococcus faecalis 2473,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.56
17976,,,1031819,[],CHEMBL679696,In vitro antibacterial activity against Escherichia coli P-5101,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.0063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0063
17977,,,1031820,[],CHEMBL701624,In vitro antibacterial activity against Klebsiella pneumoniae 13,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.025
17978,,,1031821,[],CHEMBL676659,In vitro antibacterial activity against Enterobacter cloacae 963,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.0125,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.0125
17979,,,1031822,[],CHEMBL805415,In vitro antibacterial activity against Serratia marcescens S-9,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.05
17980,,,1031823,[],CHEMBL770216,In vitro antibacterial activity against Pseudomonas aeruginosa IFO 3445,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
17981,,,1031824,[],CHEMBL731583,In vitro antibacterial activity against glucose nonfermenter Moraxella bovis P-7101,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,71931,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL614428,Moraxella bovis,Moraxella bovis,476.0,,,MIC,ug ml-1,UO_0000274,,3.13
17982,,,1031825,[],CHEMBL721372,Oral efficacy against Streptococcus pyogenes A65 on Systemic Infections in Mice,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,71931,=,1,1,=,,ED50,mg.kg-1,,23.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,23.9
17983,,,1031826,[],CHEMBL721370,Oral efficacy against Pseudomonas aeruginosa 12 on Systemic Infections in Mice,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124792,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,71931,=,1,1,=,,ED50,mg.kg-1,,2.78,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,2.78
17984,,,1037753,[],CHEMBL807465,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Staphylococcus aureus ATCC 12598,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
17985,,,1037754,[],CHEMBL807629,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
17986,,,1037755,[],CHEMBL799847,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Staphylococcus epidermidis ATCC 110001,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.78
17987,,,1037756,[],CHEMBL804853,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Streptococcus faecalis OKI 80171,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,3.12
17988,,,1037757,[],CHEMBL799653,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Salmonella typhi OKI 10084,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,<,1,1,<,,MIC,ug.mL-1,,0.39,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,0.39
17989,,,1037758,[],CHEMBL676907,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Escherichia coli OKI 35034,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,<,1,1,<,,MIC,ug.mL-1,,0.39,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.39
17990,,,1037759,[],CHEMBL768915,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Pseudomonas vulgaris OKI 60002,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,<,1,1,<,,MIC,ug.mL-1,,0.39,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.39
17991,,,1037760,[],CHEMBL764311,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.12
17992,,,1037761,[],CHEMBL689510,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Helicobacter pylori HIH 27604,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,0.78
17993,,,1037762,[],CHEMBL689511,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Helicobacter pylori HIH 27606,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,<,1,1,<,,MIC,ug.mL-1,,0.39,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,0.39
17994,,,1037763,[],CHEMBL619556,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614406,Aggregatibacter actinomycetemcomitans,Aggregatibacter actinomycetemcomitans,714.0,,,MIC,ug ml-1,UO_0000274,,0.25
17995,,,1037764,[],CHEMBL812521,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Methicillin resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
17996,,,1037765,[],CHEMBL812522,Antibacterial activity determined as minimal inhibitory concentration (MIC90) against Methicillin sensitive Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1135427,J Med Chem,2002.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,136294,=,1,1,=,,MIC90,ug.mL-1,,1.65,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.65
17997,,,1043115,[],CHEMBL766814,Inhibition of human Potassium channel HERG expressed in mammalian cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136167,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,172870,=,1,1,=,,IC50,nM,,954992.59,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.02
17998,,,1080595,[],CHEMBL752175,Antimycobacterial activity was determined against Mycobacterium smegmatis,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1149238,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Millimolar,192162,=,1,0,=,,Log of inhibitory zone,mM,,1.28,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,Log of inhibitory zone,mM,UO_0000063,,1.28
17999,,,1103700,[],CHEMBL810325,In vitro antibacterial activity against gram-positive Staphylococcus aureus NCTC 10649M,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257449,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
